Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3030408	s-mta	— (—)	5160	6378	100.00%	Distribution not available
3030408	s-mta	nmol/l (nmol/l)	713	947	47.84%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypertension

1488

1735

4.96

307.65

1.2

1.3

0.22

0.25

nmol/l

0.21

Benign neoplasm of other and unspecified endocrine glands

1306

544

31.00

307.65

1.4

1.3

0.17

0.31

nmol/l

1.09

102

Cardiovascular diseases (excluding rheumatic etc)

1038

1236

4.92

307.65

1.2

1.3

0.28

0.17

nmol/l

1.11

Benign neoplasm: Adrenal gland

1182

289

66.81

307.65

1.4

1.3

0.15

0.48

nmol/l

1.50

Secondary hypertension

336

174

20.89

307.65

1.3

0.21

0.15

nmol/l

0.96

Hypertensive diseases

1488

1736

4.96

307.65

1.2

1.3

0.22

0.25

nmol/l

0.21

Cardiovascular diseases

909

993

5.01

307.65

1.2

1.3

0.31

0.17

nmol/l

1.09

Hypertensive diseases (excluding secondary)

1128

995

6.79

307.65

1.2

1.3

0.21

0.17

nmol/l

0.44

Antihypertensive medication - note that there are other indications

897

905

5.35

307.65

1.3

0.28

0.41

nmol/l

0.37

Hypertension, essential

1524

1702

5.20

307.65

1.3

0.22

0.26

nmol/l

0.29

Disorders of other endocrine glands

901

2315

3.94

299.11

1.6

1.2

0.33

0.21

nmol/l

0.81

134

Hyperaldosteronism

192

25.09

260.88

1.2

0.37

0.42

nmol/l

—

Abnormalities of heart beat

646

1526

4.25

239.08

1.3

0.21

0.25

nmol/l

0.26

104

Benign neoplasms

1343

2570

2.92

238.45

1.4

1.2

0.22

0.27

nmol/l

0.41

143

Headache

1018

2572

3.21

237.37

1.3

0.21

0.24

nmol/l

0.19

147

Malaise and fatigue

842

1931

3.58

231.89

1.3

0.27

0.26

nmol/l

0.06

129

Metabolic disorders

1405

3169

2.75

230.85

1.3

0.21

0.22

nmol/l

0.10

101

180

Pain in throat and chest

1199

2479

2.95

222.39

1.3

0.20

0.25

nmol/l

0.53

152

Other heart diseases

651

981

4.41

220.47

1.3

0.21

0.16

nmol/l

0.52

General symptoms and signs

1476

2796

2.68

217.88

1.3

0.26

0.24

nmol/l

0.11

161

Exclusions for E4_PCOS_BROAD

426

815

5.46

211.32

2.1

1.2

0.35

0.31

nmol/l

0.11

Other disorders of fluid, electrolyte and acid-base balance

569

1331

4.19

203.86

1.2

1.3

0.30

0.26

nmol/l

0.13

Cardiac arrhythmias

867

1759

3.25

193.95

1.3

0.23

0.30

nmol/l

0.48

Abnormalities of breathing

1183

2530

2.75

192.74

1.3

0.18

0.25

nmol/l

0.91

153

Endocrine, nutritional and metabolic diseases

1005

1725

2.98

180.37

1.3

1.2

0.22

0.27

nmol/l

0.32

Anaemias

285

233

8.13

171.66

1.4

1.3

0.26

0.11

nmol/l

—

Symptoms and signs involving the circulatory and respiratory systems

1275

2539

2.54

171.09

1.3

0.19

0.24

nmol/l

0.63

154

Hypokalaemia

292

494

6.19

165.57

1.2

1.3

0.39

0.30

nmol/l

0.16

Other disorders of adrenal gland

169

163

11.33

155.51

3.2

1.2

0.45

0.35

nmol/l

0.18

Medical observation and evaluation for suspected diseases and conditions

901

1618

2.88

153.20

1.3

0.18

0.25

nmol/l

0.86

107

Other arrhythmias

929

2701

2.63

149.92

1.3

0.22

0.26

nmol/l

0.30

168

Other heart diseases, wide

1233

3240

2.35

149.52

1.3

0.21

0.26

nmol/l

0.63

189

Hyperhidrosis

133

106

13.82

138.61

1.2

1.1

0.46

0.30

nmol/l

—

Dyspnoea

1194

3973

2.25

136.43

1.3

0.29

0.22

nmol/l

0.48

250

Neoplasms

875

1722

2.72

136.24

1.4

1.1

0.25

0.17

nmol/l

0.79

Diseases of arteries, arterioles and capillaries (FINNGEN)

337

472

5.05

136.17

1.3

0.20

0.19

nmol/l

0.08

Hypertensive heart and/or renal disease

346

550

4.79

136.09

1.3

0.19

0.33

nmol/l

0.66

Cerebrovascular diseases (FINNGEN)

396

657

4.34

136.00

1.4

1.2

0.24

0.18

nmol/l

0.43

Disorders of lipoprotein metabolism and other lipidaemias

1059

2752

2.41

135.89

1.3

0.20

0.23

nmol/l

0.34

173

Hypothyroidism (congenital or acquired)

279

246

6.49

130.91

1.5

1.3

0.16

0.11

nmol/l

—

GASTRO-related operations

929

1830

2.57

127.78

1.3

1.2

0.30

0.25

nmol/l

0.29

101

Any gastric operation

929

1830

2.57

127.78

1.3

1.2

0.30

0.25

nmol/l

0.29

101

Hypothyroidism, levothyroxine purchases

272

246

6.33

125.10

1.5

1.3

0.16

0.11

nmol/l

—

Hypothyroidism and >3 levothyroxin purchases

272

246

6.33

125.10

1.5

1.3

0.16

0.11

nmol/l

—

Adrenomedullary hyperfunction

123.76

122.41

6.1

1.2

0.55

—

nmol/l

—

Episodal and paroxysmal disorders

1309

3141

2.14

121.20

1.3

0.21

0.23

nmol/l

0.22

200

Other diseases of intestines

1290

3510

2.11

118.83

1.3

0.22

0.24

nmol/l

0.14

216

Abnormal blood-pressure reading, without diagnosis

139

149

9.97

118.12

1.2

1.4

0.27

0.42

nmol/l

—

Diseases of oesophagus, stomach and duodenum

1329

3893

2.06

116.74

1.3

0.25

0.23

nmol/l

0.11

242

Paroxysmal tachycardia

292

538

4.63

115.22

1.3

1.2

0.31

0.18

nmol/l

0.74

Symptoms and signs involving cognition, perception, emotional state and behaviour

1222

4035

2.09

114.18

1.3

0.19

0.25

nmol/l

1.09

259

Dizziness and giddiness

989

3548

2.24

113.61

1.3

0.22

0.25

nmol/l

0.36

242

Tramadol

1004

2746

2.27

112.70

1.3

0.20

0.22

nmol/l

0.25

156

Hypertensive Heart Disease

294

511

4.59

112.28

1.3

1.2

0.23

0.36

nmol/l

0.45

Sleep apnoea

1196

3737

2.09

111.54

1.3

0.28

0.23

nmol/l

0.24

263

Abdominal and pelvic pain

1163

2725

2.16

110.23

1.3

0.25

0.20

nmol/l

0.54

197

Sleep apnoea, including avohilmo

1248

3801

2.05

109.56

1.3

0.27

0.23

nmol/l

0.21

261

Atrial fibrillation and flutter

364

607

3.95

107.76

1.3

0.24

0.19

nmol/l

0.38

Pain in joint

699

1725

2.61

106.90

1.3

0.18

0.22

nmol/l

0.46

119

Heart failure and antihypertensive medication

288

404

4.74

106.65

1.3

0.17

0.50

nmol/l

0.98

Other soft tissue disorders, not elsewhere classified

1136

3186

2.11

105.59

1.2

1.3

0.26

0.23

nmol/l

0.15

186

Type 2 diabetes, wide definition

1001

2962

2.19

103.92

1.3

0.18

0.26

nmol/l

1.75

173

Other headache syndromes

580

2193

2.68

103.87

1.3

0.23

0.25

nmol/l

0.11

136

Symptoms and signs involving the digestive system and abdomen

1142

2725

2.12

102.79

1.3

0.25

0.20

nmol/l

0.48

197

Pure hypercholesterolaemia

880

2553

2.28

100.84

1.3

0.22

0.23

nmol/l

0.07

165

Examination and observation for other reasons

702

1611

2.55

99.41

1.3

0.18

0.25

nmol/l

0.69

107

Pain in limb

985

3103

2.15

98.66

1.2

1.3

0.33

0.23

nmol/l

0.56

182

All kidney diseases

1199

4175

1.98

97.70

1.3

0.23

0.24

nmol/l

0.07

232

Hard cardiovascular diseases

1039

2974

2.11

96.44

1.3

0.21

0.26

nmol/l

0.55

192

Nausea and vomiting

383

1177

3.25

96.15

1.3

0.45

0.21

nmol/l

0.51

Condition for Implicit Sepsis (Organ dysfunction codes)

1103

3787

2.03

96.03

1.3

0.26

0.22

nmol/l

0.42

100

213

All chronic kidney diseases

696

2391

2.41

95.84

1.3

0.17

0.26

nmol/l

1.31

153

Other CVD (FINNGEN)

173

209

6.59

95.38

1.4

1.2

0.46

0.15

nmol/l

1.16

Depression medications

264

260

5.16

95.15

1.2

1.3

0.27

0.11

nmol/l

—

Malignant neoplasm of endocrine gland

187

354

5.58

94.57

3.2

1.2

0.48

0.39

nmol/l

0.16

Syncope and collapse

544

1777

2.65

92.58

1.3

0.38

0.26

nmol/l

0.74

127

Sleep disorders (combined)

1310

3610

1.92

91.78

1.2

1.3

0.31

0.22

nmol/l

0.53

237

Hypothyroidism, drug reimbursement

158

156

7.27

91.20

1.7

1.3

0.16

0.11

nmol/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

749

3381

2.24

90.87

1.3

0.24

0.25

nmol/l

0.09

222

Atrial fibrillation and flutter with reimbursement

295

467

4.08

90.58

1.3

0.23

0.19

nmol/l

0.23

Implicit Sepsis

1008

3646

2.04

90.55

1.3

0.29

0.22

nmol/l

0.72

220

Dorsalgia

1152

3123

1.99

90.13

1.3

0.24

0.25

nmol/l

0.11

194

Other functional intestinal disorders

578

2158

2.52

89.85

1.3

0.33

0.25

nmol/l

0.40

149

Low back pain

898

3058

2.13

89.84

1.3

0.28

0.25

nmol/l

0.21

191

Pain, not elsewhere classified

378

1247

3.08

87.59

1.3

0.27

0.23

nmol/l

0.25

Condition for Implicit Sepsis (Organ dysfunction codes)

1040

3710

2.00

87.45

1.3

0.28

0.22

nmol/l

0.62

218

Cushing syndrome

18.52

86.63

1.3

1.1

0.35

—

nmol/l

—

Persons encountering health services in other circumstances, wide

1345

3743

1.86

85.96

1.3

0.20

0.24

nmol/l

0.63

238

Codeine

1073

2936

2.00

85.48

1.3

0.26

0.22

nmol/l

0.29

158

Type 2 diabetes

1155

3530

1.93

84.19

1.3

0.16

0.26

nmol/l

2.47

192

Opioids

1114

2957

1.97

84.17

1.3

0.20

0.22

nmol/l

0.20

158

Diabetes mellitus

1192

3686

1.91

84.05

1.3

0.17

0.26

nmol/l

2.21

195

Diabetes, varying definitions

1187

3682

1.91

83.74

1.3

0.17

0.26

nmol/l

2.24

195

Ischemic heart diseases

995

2986

2.02

83.28

1.3

0.19

0.26

nmol/l

0.80

196

Implicit Sepsis

920

3436

2.04

83.15

1.3

0.27

0.23

nmol/l

0.39

218

Percutaneous Coronary Intervention

946

2854

2.05

82.92

1.3

0.22

0.26

nmol/l

0.39

194

Coronary revascularization (ANGIO or CABG)

945

2854

2.05

82.32

1.3

0.22

0.26

nmol/l

0.37

194

Neurological diseases

946

2308

2.08

81.26

1.2

1.3

0.25

0.18

nmol/l

0.65

129

Type 2 diabetes, strict (exclude DM1)

1115

3430

1.93

81.05

1.3

0.16

0.26

nmol/l

2.40

192

Other nutritional deficiencies

821

3769

2.07

80.87

1.2

1.3

0.19

0.25

nmol/l

0.51

228

Lower back pain or/and sciatica

1225

4363

1.85

80.72

1.3

0.24

0.23

nmol/l

0.08

275

Type 2 diabetes, definitions combined

1107

3405

1.93

80.48

1.3

0.16

0.26

nmol/l

2.45

189

Migraine

603

2082

2.38

80.47

1.2

1.3

0.23

0.21

nmol/l

0.12

111

Major coronary heart disease event

995

3041

1.99

80.38

1.3

0.22

0.25

nmol/l

0.30

210

Fever of other and unknown origin

601

2306

2.34

79.49

1.4

1.3

0.15

0.25

nmol/l

1.32

145

Gastro-oesophageal reflux disease

818

3438

2.07

79.45

1.3

0.27

0.23

nmol/l

0.22

228

General examination and investigation of persons without complaint and reported diagnosis

709

1617

2.31

79.39

1.3

0.19

0.25

nmol/l

0.68

107

Emergency coronary revascularization (for ACS)

1004

3120

1.98

79.14

1.3

0.22

0.25

nmol/l

0.34

222

Spondylopathies

919

2718

2.04

78.76

1.2

1.3

0.22

0.26

nmol/l

0.34

183

Benzodiazepine use

1170

4380

1.85

78.71

1.3

0.19

0.25

nmol/l

0.98

252

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

366

559

3.31

77.71

1.3

0.39

0.16

nmol/l

0.96

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1135

4235

1.86

77.65

1.3

0.24

0.23

nmol/l

0.05

100

241

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

486

1959

2.53

76.83

1.5

1.2

0.22

0.21

nmol/l

0.09

131

Codeine or tramadol medication

1288

3918

1.81

76.61

1.3

0.29

0.21

nmol/l

0.56

236

Parasetamol

805

1906

2.16

76.37

1.2

1.3

0.23

0.22

nmol/l

0.01

108

Type 2 diabetes, definitions combined, including avohilmo

1099

3405

1.90

76.20

1.3

0.17

0.26

nmol/l

2.31

189

Disorders of thyroid, IBD co-morbidities

216

349

4.41

76.04

1.2

1.3

0.16

0.14

nmol/l

—

Neurological diseases, wide definition

323

462

3.55

75.50

1.3

0.21

0.14

nmol/l

0.36

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1237

3739

1.81

73.38

1.3

0.23

0.24

nmol/l

0.09

238

Diverticular disease of intestine

812

2547

2.06

72.30

1.3

0.17

0.25

nmol/l

1.19

190

Symptoms and signs concerning food and fluid intake

171

377

4.66

71.72

1.2

1.3

0.16

0.17

nmol/l

0.07

Other symptoms and signs involving the nervous and musculoskeletal systems

545

2393

2.31

70.98

1.3

0.21

0.24

nmol/l

0.16

157

Anxiety disorders, excluding more controls

967

3319

1.91

70.66

1.3

0.20

0.27

nmol/l

0.78

180

Obesity and other hyperalimentation

764

3691

2.02

70.04

1.2

1.3

0.19

0.25

nmol/l

0.41

230

Obesity

762

3685

2.02

69.97

1.2

1.3

0.19

0.25

nmol/l

0.41

230

Mood disorders, excluding more controls

1070

3475

1.85

69.74

1.3

0.14

0.27

nmol/l

3.06

198

Irritable bowel syndrome

379

1419

2.72

69.70

1.2

1.3

0.13

0.20

nmol/l

1.59

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1059

3473

1.85

69.07

1.3

0.17

0.26

nmol/l

1.90

192

Asthma, unspecified (mode), excluding more controls

610

2076

2.22

68.62

1.2

1.3

0.33

0.24

nmol/l

0.24

111

Heart failure, not strict

873

3064

1.95

68.57

1.3

0.18

0.24

nmol/l

0.98

194

Benign neoplasm: Carotid body

52.54

68.11

4.4

1.2

0.17

—

nmol/l

—

Obesity due to excess calories

596

2765

2.18

67.88

1.2

1.3

0.20

0.22

nmol/l

0.14

165

Hyperlipidaemia, other/unspecified

451

1707

2.47

67.07

1.3

0.19

0.25

nmol/l

0.93

125

Other dorsopathies, not elsewhere classified

1091

3133

1.84

66.99

1.3

0.23

0.25

nmol/l

0.13

194

Spondylosis

629

2429

2.13

65.21

1.2

1.3

0.27

0.26

nmol/l

0.04

172

Other antidepressants

1124

3216

1.80

64.90

1.3

0.19

0.26

nmol/l

0.91

186

Asthma, unspecified (mode)

625

2213

2.15

64.89

1.2

1.3

0.32

0.24

nmol/l

0.23

127

Diabetes medication

1153

3890

1.77

64.87

1.3

0.18

0.24

nmol/l

1.41

226

First line medication for Crohn's disease

1212

3760

1.75

64.70

1.3

0.15

0.26

nmol/l

2.62

230

Anxiety disorders

1041

4059

1.80

64.19

1.3

0.19

0.23

nmol/l

0.40

241

Neurotic, stress-related and somatoform disorders

1032

4034

1.80

64.01

1.3

0.19

0.23

nmol/l

0.42

238

Persons encountering health services in other circumstances

493

2157

2.30

63.92

1.2

1.3

0.20

0.23

nmol/l

0.20

134

STROKE

638

2052

2.14

63.76

1.3

0.25

0.30

nmol/l

0.27

123

Asthma, excluding more controls

832

2210

1.98

63.75

1.2

1.3

0.30

0.24

nmol/l

0.19

114

Oedema, not elsewhere classified

371

1415

2.62

63.73

1.3

0.26

0.27

nmol/l

0.05

Other specific joint derangements/joint disorders

828

2774

1.95

63.68

1.3

0.18

0.25

nmol/l

1.01

166

Functional dyspepsia

366

1413

2.63

63.40

1.3

0.14

0.19

nmol/l

1.43

Pain (limb, back, neck, head abdominally)

727

1767

2.08

62.70

1.2

1.3

0.23

0.22

nmol/l

0.12

125

Chronic kidney disease

360

1358

2.64

62.48

1.4

1.3

0.18

0.29

nmol/l

0.95

Gastrointestinal diseases

611

1387

2.22

62.36

1.2

1.3

0.31

0.29

nmol/l

0.05

Other (not insulin) diabetes medications

1082

3632

1.78

62.11

1.3

0.17

0.24

nmol/l

1.73

219

Other special examinations and investigations of persons without complaint or reported diagnosis

674

1618

2.13

61.84

1.3

0.21

0.25

nmol/l

0.37

107

Disorders of parathyroid gland

300

1051

2.88

61.26

1.3

1.2

0.45

0.25

nmol/l

0.39

Sciatica+with lumbago

593

2616

2.11

61.02

1.2

1.3

0.22

0.26

nmol/l

0.33

165

Renal tubulo-interstitial diseases

966

4026

1.80

60.36

1.3

0.22

0.23

nmol/l

0.10

230

Diabetes, insulin treatment (Kela reimbursement)

1109

3855

1.75

60.34

1.3

0.17

0.24

nmol/l

1.71

227

Depression

1081

4217

1.75

60.20

1.3

0.14

0.27

nmol/l

3.98

235

Other intervertebral disc disorders

898

2920

1.87

60.11

1.2

1.3

0.21

0.25

nmol/l

0.38

189

Mood disorders

1144

4327

1.72

59.75

1.3

0.14

0.27

nmol/l

4.12

248

Mood [affective] disorders

1142

4327

1.72

59.64

1.3

0.14

0.27

nmol/l

4.12

248

Used for control exclusion in common control thyroid runs

1104

3177

1.77

59.56

1.3

0.19

0.23

nmol/l

0.43

203

Depression or dysthymia

753

2107

1.99

59.43

1.3

0.14

0.28

nmol/l

2.20

126

Hyperparathyroidism

268

899

3.01

59.35

1.3

1.2

0.39

0.27

nmol/l

0.21

Dorsopathies

1087

3141

1.77

59.11

1.3

0.23

0.25

nmol/l

0.12

194

Asthma

852

2361

1.91

58.83

1.2

1.3

0.29

0.24

nmol/l

0.18

131

Complications of surgical and medical care, not elsewhere classified

1091

4344

1.73

58.80

1.3

0.17

0.26

nmol/l

2.14

259

Asthma (only as main-diagnosis), excluding more controls

756

2210

1.97

58.79

1.3

0.32

0.24

nmol/l

0.25

114

Disorders of gallbladder, biliary tract and pancreas

1083

3950

1.74

58.44

1.3

0.19

0.26

nmol/l

0.99

252

Adrenocortical insufficiency

133

7.08

57.35

1.8

1.2

0.16

0.41

nmol/l

—

Asthma (mode)

838

2395

1.89

56.56

1.2

1.3

0.31

0.24

nmol/l

0.25

134

Persons encountering health services for specific procedures and health care

1163

4141

1.69

56.45

1.3

0.21

0.22

nmol/l

0.13

232

ILD medications: prednisolone, methylprednisolone, prednisone

1180

3924

1.69

56.17

1.3

0.16

0.26

nmol/l

2.44

244

Biguanides

1040

3664

1.74

55.89

1.3

0.17

0.24

nmol/l

1.86

222

Intracranial trauma

576

1953

2.09

55.19

1.2

1.3

0.24

0.19

nmol/l

0.28

110

Hypo-osmolality and hyponatraemia

227

728

3.16

54.96

1.2

1.3

0.23

0.27

nmol/l

0.26

Exclusions for E4_PCOS_CONSORTIUM

829

2835

1.85

54.28

1.5

1.2

0.37

0.19

nmol/l

0.95

151

Asthma (only as main-diagnosis)

770

2361

1.90

54.23

1.3

0.32

0.24

nmol/l

0.24

131

Oral corticosteroids

1147

4069

1.68

54.20

1.3

0.17

0.26

nmol/l

1.86

258

Anxiety (asthma-related co-morbidities)

683

2750

1.94

54.10

1.3

0.20

0.23

nmol/l

0.23

136

Fibromyalgia

161

423

3.92

53.87

1.3

0.11

0.49

nmol/l

—

Migraine without aura

252

877

2.92

53.36

1.2

0.16

0.30

nmol/l

—

Implicit viral Sepsis

356

1472

2.45

53.36

1.3

0.17

0.28

nmol/l

0.95

Ischaemic heart disease, wide definition

855

2934

1.82

53.34

1.3

0.19

0.26

nmol/l

0.83

208

Dysphagia

290

1094

2.69

52.67

1.3

0.21

0.23

nmol/l

0.21

Statin medication

729

2154

1.92

52.25

1.2

1.3

0.19

0.30

nmol/l

1.34

114

Renal failure

497

2086

2.13

52.25

1.4

1.3

0.24

0.27

nmol/l

0.17

150

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

730

3557

1.85

51.77

1.3

0.24

nmol/l

0.02

247

Any reimbursement code in KELA

589

1424

2.09

51.72

1.3

0.27

0.21

nmol/l

0.34

Primary hyperparathyroidism

196

606

3.34

51.34

1.3

0.16

0.35

nmol/l

1.66

Concussion

496

1928

2.12

50.76

1.2

1.3

0.25

0.18

nmol/l

0.29

107

Hypertensive Renal Disease

10.34

50.67

1.4

1.2

0.13

0.46

nmol/l

—

Symptoms and signs involving the skin and subcutaneous tissue

778

4273

1.80

50.66

1.3

0.20

0.25

nmol/l

0.57

270

All anxiety disorders

693

2938

1.88

50.34

1.3

0.20

0.22

nmol/l

0.20

167

Inflammatory bowel disease treatment related agents

1203

4141

1.63

50.27

1.3

0.17

0.26

nmol/l

1.90

258

Any mental disorder

1156

3514

1.66

49.65

1.3

0.18

0.27

nmol/l

1.57

202

Hypopituitarism

113

241

4.83

49.65

1.4

1.2

0.14

0.28

nmol/l

—

ILD medications

1188

3958

1.64

49.58

1.3

0.15

0.26

nmol/l

2.61

245

Disorders of mineral metabolism

136

338

4.14

49.18

1.2

1.3

0.23

0.40

nmol/l

0.62

Continuous positive airway pressure

199

525

3.24

48.41

1.2

1.3

0.11

0.19

nmol/l

—

Complications of procedures, not elsewhere classified

872

4211

1.73

48.22

1.3

0.16

0.26

nmol/l

2.32

257

Other/unspecified dorsalgia

420

1933

2.18

47.83

1.3

0.43

0.25

nmol/l

0.83

114

Recurrent or chronic depression

452

1478

2.17

47.73

1.2

1.3

0.13

0.25

nmol/l

2.31

Infections, IBD-co-morbidities

159

299

3.85

47.54

1.4

1.2

0.35

0.14

nmol/l

0.64

Constipation

945

3882

1.70

47.53

1.3

0.25

0.23

nmol/l

0.19

246

Vocal cord dysfunction

161

405

3.62

47.36

1.4

1.2

0.27

0.19

nmol/l

0.22

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

349

912

2.43

46.76

1.2

1.3

0.27

0.18

nmol/l

0.61

Disorders of the thyroid gland

976

3810

1.68

46.70

1.3

0.31

0.22

nmol/l

0.38

256

Somatoform disorder

236

855

2.82

46.59

1.3

0.14

0.29

nmol/l

1.59

Spinal stenosis

537

2059

2.00

46.41

1.2

1.3

0.27

0.26

nmol/l

0.04

163

Chronic lower respiratory diseases

1249

4209

1.59

46.12

1.3

0.23

nmol/l

0.00

255

Disturbances of skin sensation

351

1541

2.31

46.06

1.3

0.24

0.25

nmol/l

0.04

Postprocedural endocrine and metabolic disorders, not elsewhere classified

177

552

3.28

45.56

1.7

1.2

0.42

0.39

nmol/l

0.05

Hernia of abdominal wall, postoperative

196

651

3.05

45.18

1.4

1.2

0.14

0.26

nmol/l

0.55

Other metabolic disorders

183

588

3.18

44.81

1.7

1.2

0.40

0.39

nmol/l

0.01

Soft tissue disorders

1028

3209

1.66

44.74

1.2

1.3

0.19

0.23

nmol/l

0.43

187

Asthma (diagnoses ohter than nonallergic)

912

4562

1.67

44.66

1.2

1.3

0.29

0.23

nmol/l

0.25

288

Nerve, nerve root and plexus disorders

1109

4249

1.61

44.36

1.2

1.3

0.14

0.26

nmol/l

4.11

271

Non-invasive ventilation

226

730

2.79

43.41

1.5

1.3

0.19

0.18

nmol/l

0.08

Other pulmonary diagnosis

825

2379

1.75

43.10

1.3

0.23

0.24

nmol/l

0.05

131

Abnormal weight loss

149

433

3.54

43.09

1.2

1.3

0.16

0.36

nmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

439

1386

2.11

42.87

1.3

0.16

0.26

nmol/l

1.40

Lumbar disc prolapse

661

2817

1.81

42.79

1.3

0.23

0.26

nmol/l

0.16

183

Symptoms and signs involving the urinary system

807

3618

1.71

42.76

1.3

0.29

0.23

nmol/l

0.37

246

Cough

393

1757

2.14

42.43

1.2

1.3

0.19

0.25

nmol/l

0.60

120

Obesity related asthma

414

2014

2.08

41.98

1.2

1.3

0.43

0.25

nmol/l

0.34

139

Major coronary heart disease event excluding revascularizations

623

2262

1.85

41.82

1.4

1.3

0.23

0.26

nmol/l

0.31

179

Psychiatric diseases

1017

3130

1.64

41.79

1.3

0.21

0.27

nmol/l

0.46

179

Cholelithiasis, broad definition with cholecystitis

901

3677

1.66

41.66

1.3

0.20

0.26

nmol/l

0.61

243

Cholelithiasis

871

3620

1.67

41.37

1.3

0.20

0.26

nmol/l

0.63

241

Excluding asthma or asthma-COPD overlap

817

2379

1.73

41.29

1.3

0.23

0.24

nmol/l

0.11

131

Weight loss

154

473

3.34

40.80

1.2

1.3

0.16

0.36

nmol/l

—

Other anxiety disorders

500

2259

1.93

40.50

1.3

0.23

0.25

nmol/l

0.08

118

Persons encountering health services for examination and investigation

605

1618

1.89

40.40

1.3

0.21

0.25

nmol/l

0.30

107

Diarrhoea and gastroenteritis of presumed infectious origin

731

3868

1.71

40.12

1.3

0.25

nmol/l

0.01

231

Disorder of lipoprotein metabolism, unspecified

163

524

3.17

39.91

1.4

1.3

0.53

0.35

nmol/l

0.23

Migraine with aura

276

1164

2.40

39.74

1.2

1.3

0.15

0.26

nmol/l

—

Hypotension

201

728

2.81

39.72

1.4

1.3

0.47

0.25

nmol/l

0.71

Disorders of calcium metabolism

105

253

4.28

39.70

1.2

1.3

0.18

0.46

nmol/l

—

Other CVD

228

884

2.62

39.38

1.4

1.3

0.47

0.24

nmol/l

0.77

Viral Sepsis

239

955

2.54

38.80

1.3

0.16

0.25

nmol/l

1.07

Implicit viral Sepsis

238

951

2.54

38.64

1.3

0.16

0.25

nmol/l

1.07

COPD differential diagnosis

808

2395

1.70

38.38

1.3

0.23

0.24

nmol/l

0.05

134

ILD differential diagnosis

807

2395

1.70

38.16

1.3

0.23

0.24

nmol/l

0.05

134

Abnormal findings on examination of blood, without diagnosis

476

2298

1.92

38.03

1.3

0.17

0.27

nmol/l

1.43

178

Bleeding

845

3698

1.64

37.38

1.3

0.24

0.23

nmol/l

0.05

248

Haemorrhage from respiratory passages

316

1296

2.22

37.31

1.3

0.22

0.26

nmol/l

0.40

105

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

137

414

3.39

37.24

1.6

1.3

0.20

0.45

nmol/l

1.04

Cervicalgia

246

1016

2.46

37.22

1.3

1.2

0.19

0.21

nmol/l

0.11

475

2509

1.89

37.00

1.3

0.16

0.22

nmol/l

1.26

150

Hypothyroidism, other/unspecified

884

3613

1.62

36.98

1.3

0.33

0.23

nmol/l

0.41

241

Valvular heart disease excluding rheumatic fever

465

1745

1.94

36.75

1.4

1.3

0.27

0.29

nmol/l

0.09

133

Other disorders of kidney and ureter

175

619

2.89

36.31

1.4

1.3

0.28

0.27

nmol/l

0.01

Intestinal infectious diseases

1152

4337

1.52

36.29

1.3

0.20

0.24

nmol/l

0.53

270

Cholecystectomy

736

3835

1.67

36.23

1.3

0.15

0.26

nmol/l

2.42

266

Non-rheumatic valve diseases

462

1739

1.93

36.13

1.4

1.3

0.27

0.29

nmol/l

0.09

133

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

978

4076

1.57

36.07

1.4

1.3

0.25

0.23

nmol/l

0.13

255

Abnormal findings on diagnostic imaging of other body structures

192

716

2.74

36.04

1.3

0.18

0.27

nmol/l

—

Other disorders of urethra and urinary system

704

3013

1.70

36.03

1.2

1.3

0.21

0.23

nmol/l

0.11

194

Asthma, hospital admission 2, infections

604

3411

1.75

36.02

1.3

0.16

0.23

nmol/l

1.46

214

Asthma-related infections

604

3411

1.75

36.02

1.3

0.16

0.23

nmol/l

1.46

214

Certain infectious and parasitic diseases

991

3148

1.58

35.92

1.3

0.21

0.27

nmol/l

0.56

172

Malignant neoplasm of urinary organs

129

385

3.43

35.78

1.5

1.3

0.20

0.47

nmol/l

1.07

Other joint disorders

864

2817

1.63

35.23

1.3

0.15

0.25

nmol/l

2.10

170

Autoimmune diseases excluding thyroid diseases

1022

3600

1.56

35.04

1.3

0.21

0.22

nmol/l

0.16

231

Coronary atherosclerosis

643

2355

1.74

35.01

1.3

0.19

0.26

nmol/l

0.74

173

1149

3925

1.52

34.93

1.3

0.18

0.26

nmol/l

1.44

241

Diarrhoea and gastroenteritis of presumed infectious origin

1015

4356

1.54

34.83

1.3

0.23

0.24

nmol/l

0.14

267

Autoimmune diseases excluding thyroid diseases, strict definition

970

3395

1.57

34.76

1.3

0.18

0.23

nmol/l

0.83

216

COPD/asthma/ILD related infections

1058

3440

1.55

34.70

1.3

0.23

0.26

nmol/l

0.17

198

COPD/asthma related infections

1058

3440

1.55

34.70

1.3

0.23

0.26

nmol/l

0.17

198

Shoulder lesions

756

2770

1.66

34.69

1.2

1.3

0.20

0.23

nmol/l

0.25

176

Rheumatism, unspecified

192

733

2.67

34.41

1.2

1.3

0.17

0.29

nmol/l

0.67

Myocardial infarction

486

1841

1.87

34.37

1.4

1.3

0.20

0.28

nmol/l

0.75

149

Cervical disc disorders

377

1912

1.99

34.11

1.3

0.29

0.28

nmol/l

0.04

135

Complications of medical and surgical care

753

4284

1.63

34.06

1.3

0.17

0.25

nmol/l

1.79

275

Selective serotonin reuptake inhibitors

965

3227

1.57

33.91

1.3

0.24

0.26

nmol/l

0.12

186

Diaphragmatic hernia

400

2076

1.95

33.88

1.2

1.3

0.24

0.25

nmol/l

0.03

155

Malignant neoplasm of kidney, except renal pelvis

120

356

3.45

33.64

1.6

1.3

0.20

0.36

nmol/l

0.82

Hypothyreosis and Thyroxine purchase for inclusion criteria

916

3860

1.57

33.39

1.3

0.33

0.23

nmol/l

0.37

256

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

324

1575

2.08

33.08

1.2

1.3

0.48

0.28

nmol/l

0.25

102

Glucagon-like peptide-1 (GLP-1) analogues

324

1575

2.08

33.08

1.2

1.3

0.48

0.28

nmol/l

0.25

102

Visual disturbances and blindness

542

3114

1.75

32.94

1.3

0.28

0.24

nmol/l

0.17

213

Nutritional anaemias

498

2688

1.80

32.90

1.3

0.28

0.24

nmol/l

0.23

185

Clear cell adenocarcinoma of kidney

180

4.55

32.25

1.4

1.2

0.19

0.43

nmol/l

—

Intestinal infectious diseases

932

4625

1.54

32.18

1.3

0.22

0.24

nmol/l

0.21

280

Genitourinary diseases

544

1516

1.81

32.14

1.3

0.21

0.27

nmol/l

0.45

Diseases of the digestive system

455

2490

1.83

32.10

1.3

0.31

0.25

nmol/l

0.31

177

Malignant neoplasm, wide definition for exclusion

877

3287

1.57

31.99

1.6

1.2

0.20

0.24

nmol/l

0.69

185

Autoimmune diseases

1074

3629

1.51

31.87

1.3

0.28

0.23

nmol/l

0.22

232

Myalgia

268

1229

2.21

31.83

1.2

1.3

0.19

0.24

nmol/l

0.40

Other neurological diseases

723

3522

1.62

31.73

1.3

0.21

0.25

nmol/l

0.35

250

Dipeptidyl peptidase 4 (DPP-4) inhibitors

540

2486

1.75

31.62

1.3

0.19

0.25

nmol/l

1.10

184

Implicit bacterial Sepsis

441

2073

1.85

31.43

1.3

0.22

0.25

nmol/l

0.23

145

Insulin medication

570

2810

1.72

31.39

1.3

0.32

0.24

nmol/l

0.27

184

Benign neoplasm of colon, rectum, anus and anal canal

632

3316

1.67

31.24

1.4

1.3

0.18

0.25

nmol/l

0.93

259

Pain in thoracic spine

182

712

2.60

31.02

1.2

1.3

0.23

0.24

nmol/l

—

Visual disturbances

507

2917

1.75

30.78

1.3

0.29

0.25

nmol/l

0.21

198

Cystitis

829

3142

1.58

30.70

1.3

0.21

0.23

nmol/l

0.15

206

Angina pectoris

553

2131

1.74

30.68

1.3

0.22

0.27

nmol/l

0.40

164

Other symptoms and signs involving the digestive system and abdomen

190

763

2.53

30.65

1.3

0.17

0.22

nmol/l

—

Asthma, including avohilmo

1150

4408

1.47

30.59

1.2

1.3

0.29

0.22

nmol/l

0.30

290

Care involving use of rehabilitation procedures

642

3610

1.65

30.55

1.3

0.16

0.22

nmol/l

1.11

220

Acute upper respiratory infections

1023

4221

1.50

30.44

1.3

0.18

0.25

nmol/l

1.03

268

Asthma, hospital admissions , main diagnosis only

808

4599

1.56

30.43

1.2

1.3

0.33

0.22

nmol/l

0.41

287

Disorders of eyelid, lacrimal system and orbit

846

4167

1.55

30.41

1.2

1.3

0.18

0.24

nmol/l

1.09

291

Oxycodone

377

1791

1.92

30.29

1.3

0.19

0.22

nmol/l

0.33

130

Iron deficiency anaemia

429

2326

1.83

30.22

1.3

0.24

0.26

nmol/l

0.12

156

Other and unspecified iron deficiency

351

1814

1.95

30.09

1.3

0.26

0.24

nmol/l

0.12

120

Aplastic and other anaemias

441

2284

1.81

29.82

1.4

1.3

0.26

nmol/l

0.01

159

Other bacterial diseases

992

4216

1.50

29.71

1.3

0.21

0.25

nmol/l

0.61

244

Abnormal involuntary movements

166

635

2.66

29.69

1.3

0.39

0.29

nmol/l

—

Adverse effects, not elsewhere classified

233

1042

2.27

29.52

1.2

1.3

0.21

0.29

nmol/l

—

Diseases of the ear and mastoid process

1139

3914

1.47

29.19

1.3

0.21

0.24

nmol/l

0.33

246

Personality disorders, excluding more controls

258

1206

2.16

29.18

1.2

1.3

0.15

0.29

nmol/l

1.68

Implicit bacterial Sepsis

400

1924

1.86

28.98

1.3

0.19

0.25

nmol/l

0.60

139

Benign neoplasm of other and ill-defined parts of digestive system

219

964

2.31

28.88

1.5

1.3

0.29

0.27

nmol/l

0.05

Use of hypnotics and sedatives

1039

4042

1.48

28.85

1.3

0.16

0.27

nmol/l

2.89

236

Finngen Rheumatological endpoints

928

3494

1.52

28.79

1.3

0.19

0.23

nmol/l

0.39

214

Migraine without aura and triptan purchases

192

801

2.43

28.57

1.2

1.3

0.11

0.34

nmol/l

—

Insulin, intermediate and long-acting

532

3075

1.69

28.47

1.3

0.30

0.23

nmol/l

0.23

223

Other and unspecified effects of external causes

299

1498

2.02

28.16

1.2

0.27

0.24

nmol/l

0.11

Disorders of vestibular function (Vertigo)

487

2795

1.73

28.10

1.3

0.17

0.24

nmol/l

1.11

202

Obesity, other/unspecified

362

1938

1.89

27.99

1.2

1.3

0.15

0.21

nmol/l

1.05

113

Other bacterial diseases

919

4135

1.50

27.96

1.3

0.20

0.25

nmol/l

0.98

251

Diseases of arteries, arterioles and capillaries

642

2942

1.62

27.88

1.3

0.23

0.25

nmol/l

0.13

217

Paralytic ileus and intestinal obstruction

251

1182

2.14

27.87

1.3

0.20

0.29

nmol/l

0.48

Substance abuse, excluding more controls

508

2547

1.71

27.76

1.2

1.3

0.15

0.30

nmol/l

2.54

156

Other diseases of upper respiratory tract

1058

3769

1.47

27.58

1.3

0.22

0.25

nmol/l

0.24

235

Nonorganic sleeping disorders, excluding more controls

206

902

2.31

27.44

1.3

0.22

0.29

nmol/l

0.36

Exposure to unspecified factor

962

4706

1.48

27.44

1.3

0.29

0.23

nmol/l

0.40

298

Certain infectious and parasitic diseases

724

2280

1.60

27.42

1.3

0.27

0.26

nmol/l

0.05

137

Diseases of inner ear

547

3208

1.66

27.23

1.3

0.23

0.24

nmol/l

0.10

225

Diseases of pulp and periapical tissues, including avohilmo

1010

3552

1.48

27.21

1.2

1.3

0.26

0.23

nmol/l

0.19

242

Diseases of the skin and subcutaneous tissue

957

3219

1.50

27.20

1.3

0.22

0.25

nmol/l

0.19

203

Subjective visual disturbances

284

1416

2.03

27.18

1.3

0.25

nmol/l

0.01

Dermatitis and eczema

1066

4570

1.45

27.09

1.3

0.28

0.23

nmol/l

0.31

298

Ovarian cyst

374

1139

1.91

27.04

1.2

0.14

0.20

nmol/l

0.88

Cerebrovascular diseases

716

3231

1.57

26.67

1.4

1.3

0.19

0.25

nmol/l

0.68

236

Other and unspecified anaemias

398

2122

1.80

26.48

1.4

1.3

0.28

0.27

nmol/l

0.03

150

Other anaemias

401

2138

1.80

26.44

1.4

1.3

0.28

0.27

nmol/l

0.05

153

Any event in cancer register

888

3499

1.50

26.44

1.6

1.2

0.19

0.24

nmol/l

0.58

199

Urticaria and erythema

387

2154

1.81

26.43

1.3

1.2

0.30

0.23

nmol/l

0.46

121

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

104

329

3.23

26.39

1.2

—

0.18

nmol/l

—

Osteopathies and chondropathies

565

3245

1.63

26.20

1.3

0.24

0.22

nmol/l

0.10

200

Adjustment and management of implanted device

189

815

2.35

26.14

1.3

0.29

nmol/l

0.01

Autoimmune diseases related-to ILD

821

4703

1.50

25.99

1.3

0.16

0.25

nmol/l

2.39

297

Hypothyroidism, strict autoimmune

670

2800

1.58

25.79

1.2

1.3

0.34

0.24

nmol/l

0.27

189

Diseases of the musculoskeletal system and connective tissue

480

1379

1.75

25.79

1.3

0.26

0.27

nmol/l

0.04

Non-selective monoamine reuptake inhibitors

385

2075

1.80

25.74

1.3

0.15

0.24

nmol/l

2.40

121

Myocardial infarction, without ST-elevation

365

1826

1.84

25.68

1.3

0.17

0.29

nmol/l

1.41

149

Bacterial Sepsis

437

2157

1.74

25.60

1.3

0.19

0.26

nmol/l

0.73

151

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

507

2979

1.66

25.54

1.3

0.20

0.25

nmol/l

0.33

192

Polyuria

226

1063

2.15

25.31

1.3

0.35

0.30

nmol/l

0.12

Chronic gastritis

272

1370

2.01

25.29

1.3

0.21

0.27

nmol/l

0.31

101

Chronic pancreatitis

146

569

2.61

25.23

1.4

1.3

0.19

0.29

nmol/l

0.73

Urticaria

318

1693

1.90

25.10

1.2

1.3

0.29

0.24

nmol/l

0.26

Other reaction to severe stress, and adjustment disorders

362

2009

1.82

24.98

1.3

1.2

0.14

0.24

nmol/l

2.00

104

Infections of the skin and subcutaneous tissue

558

3445

1.61

24.97

1.3

0.20

0.25

nmol/l

0.53

214

Other systemic involvement of connective tissue (FG)

280

1414

1.98

24.86

1.3

0.14

0.24

nmol/l

1.90

101

Rotator cuff syndrome

572

2546

1.62

24.78

1.2

1.3

0.19

0.23

nmol/l

0.28

167

Acute upper respiratory infections of multiple and unspecified sites

717

3478

1.54

24.77

1.2

1.3

0.17

0.26

nmol/l

0.99

220

Other noninfective gastroenteritis and colitis

257

1279

2.03

24.69

1.3

0.21

0.25

nmol/l

0.27

Endometriosis

356

1126

1.87

24.30

1.3

0.37

0.20

nmol/l

0.48

Other gastritis (incl. Duodenitis)

228

1095

2.11

24.21

1.2

1.3

0.14

0.21

nmol/l

1.51

Insulin, combination of fast acting with intermediate-acting or long-acting

570

3282

1.60

24.12

1.3

0.32

0.23

nmol/l

0.33

234

Other diseases of urinary system

927

3577

1.46

24.11

1.3

0.25

0.23

nmol/l

0.21

231

Diseases of the eye and adnexa

755

2478

1.53

24.00

1.2

1.3

0.32

0.21

nmol/l

0.53

175

Hyperkalaemia

169

4.05

23.91

1.3

0.13

0.41

nmol/l

—

Polyarthropathies

613

2538

1.59

23.88

1.2

1.3

0.21

0.26

nmol/l

0.45

162

Convulsions, not elsewhere classified

205

936

2.18

23.88

1.3

0.18

0.23

nmol/l

0.37

Heart failure,strict

495

2109

1.67

23.85

1.3

0.16

0.24

nmol/l

1.50

153

Benign neoplasm: Colon

519

3069

1.63

23.79

1.4

1.3

0.20

0.25

nmol/l

0.61

251

Covid-19 confirmed case

352

1969

1.80

23.70

1.3

0.43

0.27

nmol/l

0.58

130

Other diseases of the digestive system

297

1579

1.90

23.55

1.3

0.36

0.28

nmol/l

0.28

115

Malignant neoplasm

804

3199

1.49

23.47

1.6

1.2

0.20

0.24

nmol/l

0.66

183

Arthropathies

828

2822

1.49

23.34

1.3

0.17

0.25

nmol/l

1.36

170

Systemic connective tissue disorders

363

2060

1.78

23.32

1.3

1.2

0.14

0.24

nmol/l

2.60

135

155

645

2.44

23.32

1.4

1.3

0.19

0.31

nmol/l

0.63

GI-bleeding

295

1573

1.89

23.18

1.3

0.37

0.28

nmol/l

0.31

115

Chronic apical periodontitis

1062

4296

1.41

23.07

1.2

1.3

0.25

0.23

nmol/l

0.14

274

Solid cancers, helper endpoint

793

3155

1.49

22.94

1.6

1.2

0.20

0.24

nmol/l

0.58

183

Enthesopathies of lower limb, excluding foot

226

1107

2.06

22.79

1.2

0.12

0.20

nmol/l

1.80

Other enthesopathies

298

1604

1.87

22.79

1.2

1.3

0.20

0.25

nmol/l

0.26

Hernia

896

4176

1.44

22.59

1.3

0.27

0.23

nmol/l

0.26

262

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

587

3745

1.56

22.54

1.3

0.16

0.25

nmol/l

1.70

251

Heart failure and coronary heart disease

370

1485

1.78

22.48

1.3

0.17

0.29

nmol/l

1.22

119

Disorders of conjunctiva

793

4354

1.47

22.47

1.3

0.25

0.24

nmol/l

0.05

276

Cervicobrachial syndrome

227

1121

2.05

22.39

1.2

1.3

0.27

0.20

nmol/l

0.20

Factors influencing health status and contact with health services

244

585

2.10

22.37

1.3

1.2

0.35

0.19

nmol/l

0.50

Falls/tendency to fall

1037

3679

1.42

22.28

1.3

0.22

0.23

nmol/l

0.07

219

Noninfective enteritis and colitis

450

2739

1.65

22.20

1.3

0.19

0.24

nmol/l

0.58

169

Unstable angina pectoris

331

1446

1.82

22.17

1.3

0.25

0.30

nmol/l

0.23

121

Codes for special purposes

496

3093

1.61

22.13

1.2

1.3

0.41

0.24

nmol/l

0.73

187

Provisional assignment of new diseases of uncertain etiology

495

3087

1.61

22.08

1.2

1.3

0.41

0.24

nmol/l

0.73

187

Cluster headache, wide

140

4.26

22.03

1.5

0.10

0.51

nmol/l

—

Other and unspecified urticaria

217

1063

2.07

21.93

1.2

0.35

0.28

nmol/l

0.27

Behavioural syndromes associated with physiological disturbances and physical factors

876

4334

1.44

21.92

1.3

0.22

0.25

nmol/l

0.24

258

Heartburn

119

451

2.68

21.80

1.2

1.3

0.12

0.29

nmol/l

—

Enlarged lymph nodes

154

659

2.36

21.75

1.3

0.36

0.17

nmol/l

0.48

Myocardial infarction, strict

410

1720

1.71

21.74

1.4

1.3

0.19

0.29

nmol/l

1.00

134

Benign paroxysmal vertigo

304

1678

1.83

21.52

1.3

0.18

0.23

nmol/l

0.67

128

Caries of dentine

224

1085

2.03

21.51

1.3

0.17

0.25

nmol/l

0.71

Asthma/COPD (KELA code 203)

876

4204

1.43

21.42

1.2

1.3

0.30

0.23

nmol/l

0.23

254

Bronchitis

1005

4528

1.40

21.41

1.2

1.3

0.16

0.25

nmol/l

1.59

286

Diseases of the respiratory system

607

1951

1.57

21.30

1.3

0.30

0.26

nmol/l

0.15

112

Other disorders of lacrimal gland

358

2079

1.74

21.27

1.2

1.3

0.15

0.22

nmol/l

1.28

150

Panic disorder

157

685

2.32

21.24

1.4

1.3

0.13

0.37

nmol/l

1.46

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

823

3439

1.45

21.22

1.3

0.24

0.26

nmol/l

0.16

198

823

3439

1.45

21.22

1.3

0.24

0.26

nmol/l

0.16

198

Fall on same level

1074

4232

1.39

21.14

1.3

0.21

0.24

nmol/l

0.22

247

Migraine with aura and triptan purchases

170

769

2.24

21.11

1.2

1.3

0.16

0.37

nmol/l

—

Abnormal findings on diagnostic imaging of lung

441

2593

1.64

21.11

1.3

0.23

0.25

nmol/l

0.10

208

Sleep disorders

843

4255

1.44

21.06

1.3

0.22

0.25

nmol/l

0.19

247

Dental caries

247

1233

1.94

20.98

1.4

1.3

0.16

0.30

nmol/l

1.03

Disorders of lacrimal system

424

2581

1.65

20.87

1.2

1.3

0.15

0.21

nmol/l

1.14

188

Disorders of synovium and tendon

490

2699

1.60

20.87

1.2

1.3

0.23

nmol/l

0.01

161

Dermatitis

582

3808

1.53

20.86

1.3

0.38

0.23

nmol/l

0.66

251

Other and unspecified dermatitis

498

3164

1.58

20.74

1.3

0.38

0.24

nmol/l

0.54

208

Dialysis, with operation codes

136

564

2.45

20.70

1.4

1.3

0.22

0.31

nmol/l

0.45

Gonarthrosis [arthrosis of knee](FG)

705

2755

1.49

20.67

1.2

1.3

0.28

0.24

nmol/l

0.16

195

Glomerular disorders in diseases classified elsewhere

129

523

2.51

20.63

1.2

1.3

0.18

0.32

nmol/l

0.90

Extracorporeal dialysis

237

3.33

20.56

1.4

1.3

0.28

0.35

nmol/l

0.24

Intestinal stricture

297

1651

1.81

20.53

1.4

1.3

0.19

0.26

nmol/l

0.63

120

COPD (mode)

289

1237

1.85

20.45

1.3

0.17

0.24

nmol/l

1.20

Glomerular diseases

185

877

2.14

20.45

1.2

1.3

0.16

0.25

nmol/l

0.76

External causes of morbidity and mortality

625

2043

1.54

20.39

1.3

0.32

0.23

nmol/l

0.40

118

Other or unspecified ileus, impaction or obstruction

171

788

2.19

20.26

1.3

0.13

0.23

nmol/l

1.59

Other systemic involvement of connective tissue

285

1574

1.83

20.17

1.3

0.14

0.25

nmol/l

2.04

103

Gonarthrosis

593

2198

1.54

20.16

1.2

1.3

0.17

0.26

nmol/l

1.45

158

Gingivitis and periodontal diseases

962

3541

1.41

20.09

1.3

0.21

0.26

nmol/l

0.65

232

Acute sinusitis

489

2882

1.58

19.97

1.3

0.17

0.21

nmol/l

0.51

167

Dental pulpitis, including avohilmo

857

3927

1.42

19.87

1.2

1.3

0.27

0.24

nmol/l

0.19

245

Care involving dialysis

349

2.83

19.75

1.4

0.24

0.31

nmol/l

0.30

Persons encountering health services for specific procedures, not carried out

101

371

2.77

19.74

1.4

1.3

0.34

0.39

nmol/l

0.15

Coxibs

237

626

2.01

19.49

1.3

0.18

0.25

nmol/l

—

Malignant neoplasm of thyroid gland, including Hilmo

101

375

2.75

19.40

1.9

1.2

0.11

0.38

nmol/l

—

Epilepsy

262

1422

1.85

19.38

1.3

0.20

0.26

nmol/l

0.60

108

Other diseases of pancreas

103

387

2.71

19.32

1.3

0.13

0.33

nmol/l

—

Candidiasis

292

1648

1.79

19.24

1.3

0.27

0.25

nmol/l

0.11

103

Tinnitus

242

1290

1.90

19.22

1.3

0.17

0.22

nmol/l

—

103

Conjunctivitis

711

4108

1.45

19.21

1.2

1.3

0.26

0.22

nmol/l

0.26

250

Influenza and pneumonia

977

4512

1.38

19.12

1.4

1.3

0.24

nmol/l

0.00

259

Acute renal failure

199

998

2.01

18.91

1.3

0.29

0.26

nmol/l

0.11

Heart failure, strict

528

2422

1.55

18.84

1.3

0.18

0.27

nmol/l

1.18

185

Persons with potential health hazards related to communicable diseases

343

2022

1.69

18.68

1.3

0.21

nmol/l

0.02

Generalized anxiety disorder

158

730

2.19

18.67

1.3

0.12

0.37

nmol/l

1.56

Cluster headache, wide,, including avohilmo

226

3.26

18.67

1.4

1.3

0.12

0.48

nmol/l

—

Pacemaker

279

1499

1.80

18.66

1.3

0.27

0.29

nmol/l

0.07

120

Thyrotoxicosis, other and/or unspecified

212

1093

1.96

18.64

1.2

1.3

0.32

0.26

nmol/l

—

Hypercalcemia

188

3.50

18.48

1.2

0.17

0.49

nmol/l

—

Other symptoms and signs involving cognitive functions and awareness

395

2218

1.63

18.44

1.3

0.18

0.27

nmol/l

1.00

167

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

536

3552

1.52

18.40

1.3

0.16

0.25

nmol/l

1.56

241

COPD

394

1979

1.64

18.38

1.3

0.19

0.25

nmol/l

0.84

153

Nephropathy related operations

131

565

2.35

18.33

1.4

1.3

0.25

0.29

nmol/l

0.19

Other external causes of accidental injury

767

2674

1.44

18.31

1.3

0.18

0.24

nmol/l

0.60

161

Disorders of skin appendages

452

2891

1.57

18.28

1.2

1.3

0.15

0.23

nmol/l

1.23

176

Inflammatory diseases of female pelvic organs

595

2945

1.49

18.18

1.2

1.3

0.19

0.22

nmol/l

0.28

158

Urolithiasis

285

1625

1.77

18.15

1.2

1.3

0.14

0.30

nmol/l

1.98

118

Polycystic ovarian syndrome, consortium definition

689

2813

1.46

17.99

1.3

0.26

0.21

nmol/l

0.31

149

Soft tissue disorders related to use, overuse and pressure

261

1456

1.81

17.92

1.2

1.3

0.23

0.26

nmol/l

0.14

Injuries to the head

1015

4605

1.36

17.91

1.2

1.3

0.30

0.21

nmol/l

0.72

279

Haemorrhoids and perianal venous thrombosis

278

1577

1.77

17.86

1.2

1.3

0.31

0.27

nmol/l

0.17

121

Acute tubulo-interstitial nephritis

557

3221

1.50

17.84

1.4

1.3

0.28

0.24

nmol/l

0.17

196

Cerebral cysts

228

3.18

17.72

1.4

1.3

0.11

0.43

nmol/l

—

Insulin, fast-acting

326

1941

1.69

17.71

1.3

0.19

0.26

nmol/l

0.83

127

Cluster headache, strict, including avohilmo

208

3.30

17.70

1.4

1.3

0.12

0.45

nmol/l

—

Other congenital malformations

376

2.65

17.61

2.2

1.3

0.17

0.44

nmol/l

—

Cutaneous abscess, furuncle and carbuncle

253

1406

1.82

17.61

1.3

0.20

0.22

nmol/l

0.19

Diseases of salivary glands

322

1917

1.69

17.58

1.3

0.16

0.23

nmol/l

1.19

118

Carbimazole or st.post thyroidectomy, condition for graves disease

222

1186

1.89

17.58

1.5

1.3

0.36

0.26

nmol/l

0.27

Carpal tunnel syndrome

573

3418

1.49

17.57

1.2

1.3

0.14

0.26

nmol/l

3.08

228

All-cause Heart Failure

514

2384

1.53

17.55

1.3

0.18

0.27

nmol/l

1.22

180

Nonorganic sleeping disorders

206

1075

1.94

17.50

1.3

0.22

0.26

nmol/l

0.21

Cyst of kidney

311

2.82

17.41

1.3

0.39

0.35

nmol/l

—

Conduction disorders

249

1108

1.83

17.39

1.3

0.23

0.34

nmol/l

0.48

Algoneurodystrophy

143

3.82

17.39

1.2

1.3

0.10

0.60

nmol/l

—

Unspecified haematuria

359

1814

1.65

17.35

1.3

0.17

0.27

nmol/l

1.23

140

Undetermined asthma, excluding more controls

131

580

2.28

17.21

1.2

1.3

0.15

0.26

nmol/l

—

Mental and behavioural disorders due to psychoactive substance use

522

3232

1.50

17.17

1.2

1.3

0.15

0.27

nmol/l

2.65

203

Other extrapyramidal and movement disorders in other diseases

233

1275

1.85

17.10

1.3

0.41

0.18

nmol/l

0.69

Substance abuse

508

3176

1.51

17.10

1.2

1.3

0.15

0.27

nmol/l

2.58

198

Malignant neoplasm of thyroid gland

337

2.73

17.07

1.9

1.2

0.12

0.40

nmol/l

—

Ocular pain

383

2.60

17.03

1.3

0.12

0.39

nmol/l

—

Other diseases of anus and rectum

256

1439

1.79

17.01

1.3

0.21

0.28

nmol/l

0.40

105

Cardiomyopathy

156

745

2.11

16.98

1.3

0.24

0.39

nmol/l

0.55

Chronic rhinitis, nasopharyngitis and pharyngitis

308

1830

1.70

16.94

1.2

1.3

0.13

0.23

nmol/l

2.33

115

Thyrotoxicosis

263

1497

1.77

16.93

1.2

1.3

0.27

0.25

nmol/l

0.04

Substance use, excluding alcohol

201

1053

1.93

16.90

1.2

1.3

0.16

0.27

nmol/l

1.18

Noninfectious colitis NAS

142

657

2.19

16.81

1.3

0.22

0.33

nmol/l

—

Collagenous colitis

109

452

2.45

16.73

1.3

1.2

0.23

0.38

nmol/l

0.58

Disorders resulting from impaired renal tubular function

138

3.80

16.66

1.4

0.20

0.37

nmol/l

—

Gastroduodenal ulcer

218

1175

1.86

16.60

1.3

0.37

0.27

nmol/l

0.23

Other arthrosis

469

2118

1.54

16.56

1.3

0.25

0.26

nmol/l

0.09

154

Injuries to the ankle and foot

637

3960

1.44

16.47

1.2

1.3

0.24

0.22

nmol/l

0.14

235

Insomnia

802

4232

1.39

16.46

1.3

0.22

nmol/l

0.02

240

Calculus of kidney and ureter

266

1532

1.75

16.42

1.2

1.3

0.15

0.31

nmol/l

1.76

111

Insulin, fast-acting or short human

328

1998

1.65

16.37

1.3

0.19

0.25

nmol/l

0.75

132

Injuries to the knee and lower leg

1077

4504

1.33

16.31

1.2

1.3

0.18

0.25

nmol/l

1.46

270

Sequelae of external causes of morbidity and mortality

246

1390

1.79

16.25

1.3

0.17

0.23

nmol/l

0.64

Undetermined asthma

131

596

2.22

16.15

1.2

1.3

0.15

0.26

nmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

467

2546

1.52

16.11

1.3

0.18

0.27

nmol/l

1.49

192

Sequelae with surgical and medical care as external cause

200

1064

1.90

16.09

1.3

0.18

0.24

nmol/l

0.64

Pneumonias (Asthma/COPD co-morbidities)

915

4554

1.35

16.01

1.3

0.24

nmol/l

0.01

267

Triptan medication for migraine, single purchase ok

721

3490

1.41

15.86

1.3

0.21

0.22

nmol/l

0.07

204

Migraine, single triptan purchase ok & required. ICD-code if available is included

721

3490

1.41

15.86

1.3

0.21

0.22

nmol/l

0.07

204

Periodontitis

883

4363

1.36

15.80

1.3

0.20

0.24

nmol/l

0.53

284

All pneumoniae

918

4560

1.35

15.78

1.3

0.24

nmol/l

0.02

267

Other and unspecified polyneuropathies, also in other diseases

177

910

1.97

15.78

1.4

1.3

0.20

0.25

nmol/l

—

Chronic periodontitis, including avohilmo

881

4363

1.36

15.77

1.3

0.20

0.24

nmol/l

0.53

284

Intracranial injury

510

3268

1.48

15.76

1.2

1.3

0.25

0.23

nmol/l

0.07

220

Transient ischemic attack

464

2487

1.52

15.70

1.3

0.25

nmol/l

0.00

200

Other diseases of intestine

139

656

2.14

15.68

1.4

1.3

0.10

0.22

nmol/l

—

Personality disorders

258

1494

1.74

15.66

1.2

0.14

0.24

nmol/l

1.51

Excessive, frequent and irregular menstruation

350

1171

1.65

15.56

1.3

0.21

0.20

nmol/l

0.06

Other chronic obstructive pulmonary disease

368

1913

1.60

15.53

1.3

0.17

0.25

nmol/l

1.36

146

Erysipelas

647

3490

1.42

15.51

1.2

1.3

0.19

0.25

nmol/l

0.64

225

Hypothyroidism, strict autoimmune, 3 medication purchases required

739

3596

1.39

15.49

1.2

1.3

0.34

0.23

nmol/l

0.33

233

Diseases of liver

320

1968

1.64

15.47

1.3

0.16

0.26

nmol/l

1.76

135

Other disorders of eye and adnexa

147

713

2.09

15.45

1.2

1.3

0.12

0.36

nmol/l

2.16

Osteoporosis

260

1412

1.74

15.45

1.4

1.2

0.25

nmol/l

0.02

Accidents

746

2674

1.40

15.38

1.3

0.18

0.24

nmol/l

0.57

161

Bacterial infection, other or unspecified

507

2907

1.48

15.37

1.4

1.3

0.20

0.27

nmol/l

0.87

199

Other symptoms and signs involving the urinary system

101

421

2.43

15.33

1.4

1.3

0.46

0.35

nmol/l

0.27

Arthrosis

626

2392

1.44

15.32

1.2

1.3

0.15

0.26

nmol/l

2.23

162

Brachial plexus disorders

101

422

2.43

15.26

1.2

1.3

0.14

0.38

nmol/l

—

Other disorders of bladder

118

528

2.26

15.22

1.2

1.3

0.30

0.25

nmol/l

—

Pneumonia, organism unspecified

826

4265

1.36

15.21

1.3

0.25

0.24

nmol/l

0.05

252

Polyneuropathies and other disorders of the peripheral nervous system

198

1070

1.87

15.19

1.3

0.19

0.27

nmol/l

0.72

Benign neoplasm of brain and other parts of central nervous system

283

2.77

15.18

2.1

1.2

0.12

0.39

nmol/l

—

Other disorders of skin and subcutaneous tissue

617

3876

1.42

15.09

1.3

0.17

0.25

nmol/l

1.61

269

Other disorders of ear

829

4000

1.36

15.07

1.3

0.23

nmol/l

0.00

267

Early onset COPD, excluding more controls

180

946

1.92

15.00

1.2

1.3

0.15

0.25

nmol/l

1.55

Pain associated with micturition

123

565

2.21

14.90

1.2

1.3

0.18

0.33

nmol/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

431

2479

1.52

14.87

1.2

1.3

0.24

0.22

nmol/l

0.08

128

COPD related to multimorbidity

326

1709

1.62

14.79

1.3

0.17

0.30

nmol/l

1.50

139

AV-block

146

625

2.06

14.68

1.3

0.15

0.46

nmol/l

1.37

Polyarthrosis

204

1042

1.83

14.63

1.2

1.3

0.13

0.27

nmol/l

2.63

Explicit Sepsis

370

2227

1.56

14.51

1.4

1.2

0.19

0.25

nmol/l

0.58

150

Smoking dependency

414

2.41

14.50

1.2

1.3

0.18

0.38

nmol/l

1.09

Mental and behavioural disorders due to tobacco

415

2.40

14.42

1.2

1.3

0.18

0.37

nmol/l

1.06

Congenital malformations, deformations and chromosomal abnormalities

568

3681

1.43

14.40

1.5

1.3

0.17

0.22

nmol/l

0.83

210

ILD medications: immunosuppressive drugs

560

3659

1.43

14.22

1.2

1.3

0.22

0.26

nmol/l

0.30

230

Other septicaemia

317

1908

1.61

14.20

1.4

1.3

0.19

0.30

nmol/l

1.10

134

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

886

4545

1.33

14.18

1.3

0.24

nmol/l

0.04

268

Gonarthrosis,primary

783

3553

1.36

14.17

1.2

1.3

0.27

0.23

nmol/l

0.12

265

Unspecified kidney failure

371

2.46

14.03

1.4

1.3

0.18

0.36

nmol/l

0.97

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

342

2.53

13.99

1.4

1.3

0.22

0.28

nmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

519

3444

1.44

13.94

1.5

1.3

0.18

0.23

nmol/l

0.64

195

Transport accidents

406

2313

1.52

13.92

1.2

1.3

0.15

0.25

nmol/l

1.39

139

Aortic aneurysm

176

924

1.88

13.89

1.2

1.3

0.11

0.34

nmol/l

—

Disorders of vitreous body

453

2978

1.48

13.84

1.2

1.3

0.20

0.24

nmol/l

0.37

227

Diseases of oral cavity, salivary glands and jaws

517

1819

1.47

13.77

1.3

0.30

0.28

nmol/l

0.09

135

Phobic anxiety disorders

124

589

2.12

13.75

1.2

1.3

0.19

0.34

nmol/l

—

Extrapyramidal and movement disorders

335

2148

1.57

13.66

1.3

0.55

0.20

nmol/l

3.17

146

Stroke, excluding SAH

516

2614

1.45

13.66

1.4

1.3

0.23

0.26

nmol/l

0.20

202

Implicit fungal Sepsis

294

2.63

13.59

1.5

1.2

0.36

0.45

nmol/l

—

Allergic asthma (mode), excluding more controls

197

1076

1.80

13.58

1.2

1.3

0.20

0.26

nmol/l

—

Disorders of vitreous body and globe

462

3045

1.47

13.53

1.2

1.3

0.20

0.25

nmol/l

0.54

235

Later onset COPD, excluding more controls

180

747

1.88

13.50

1.4

1.3

0.18

0.30

nmol/l

1.25

Radiculopathy

144

731

1.99

13.39

1.4

1.3

0.41

0.22

nmol/l

—

Abnormalities of gait and mobility

112

519

2.18

13.33

1.3

0.16

0.30

nmol/l

—

Cardiodefibrillation

296

1852

1.61

13.29

1.3

0.26

0.29

nmol/l

0.11

163

Mouth breathing

355

2318

1.54

13.28

1.2

1.3

0.12

0.24

nmol/l

4.28

168

Cardiomyopathy, other and unspecified

321

2.53

13.26

1.3

0.39

0.35

nmol/l

—

Vascular disorders of the intestines

235

2.81

13.22

1.2

0.30

0.36

nmol/l

—

Stroke, including SAH

542

2770

1.43

13.22

1.4

1.3

0.22

0.25

nmol/l

0.27

208

Presence of other functional implants

508

2450

1.44

13.21

1.3

0.27

0.24

nmol/l

0.13

200

Acetic acid derivatives and related substances

214

618

1.81

13.13

1.2

1.3

0.19

0.25

nmol/l

0.34

Gout

216

1096

1.75

13.12

1.2

1.3

0.23

0.28

nmol/l

0.22

100

Bacterial infection, other or unspecified

454

2704

1.46

13.09

1.4

1.3

0.21

0.27

nmol/l

0.74

188

Meniscus derangement

478

2215

1.46

13.09

1.3

0.16

0.26

nmol/l

2.11

158

Volume depletion

306

2.54

12.99

1.5

1.3

0.18

0.32

nmol/l

—

Benign neoplasm: Kidney

153

3.29

12.96

1.4

1.3

0.22

0.49

nmol/l

—

Acute bronchitis

344

2202

1.54

12.90

1.2

1.3

0.14

0.25

nmol/l

2.53

151

Gastric ulcer

148

771

1.94

12.78

1.3

0.49

0.25

nmol/l

0.43

Injuries to the neck

206

1189

1.75

12.77

1.2

1.3

0.13

0.26

nmol/l

1.91

Disorders of adult personality and behaviour

256

1566

1.65

12.75

1.2

0.14

0.24

nmol/l

1.60

Erysipelas

478

2953

1.44

12.64

1.2

1.3

0.15

0.26

nmol/l

2.41

209

Nontoxic goitre/thyroid nodule

289

1826

1.60

12.64

1.3

0.35

0.22

nmol/l

0.56

122

Other diseases of hard tissues of teeth

506

1816

1.45

12.60

1.3

0.29

0.28

nmol/l

0.04

135

Disease of hard tissues of teeth, NOS

496

1795

1.45

12.59

1.2

1.3

0.17

0.28

nmol/l

1.08

132

Other diseases of liver

176

975

1.82

12.58

1.4

1.3

0.16

0.27

nmol/l

1.16

Chronic sinusitis

374

2500

1.50

12.56

1.2

1.3

0.16

0.23

nmol/l

1.45

157

Injury, poisoning and certain other consequences of external causes

466

1596

1.47

12.47

1.2

1.3

0.40

0.25

nmol/l

0.54

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

201

2.63

12.37

1.5

1.3

0.15

nmol/l

—

Allergic asthma (mode)

197

1108

1.75

12.35

1.2

1.3

0.20

0.25

nmol/l

—

Pregnancy hypertension

374

2243

1.50

12.34

1.2

1.3

0.25

0.23

nmol/l

0.10

117

Ventral hernia

217

1284

1.70

12.32

1.4

1.3

0.15

0.24

nmol/l

1.31

Other noninflammatory disorders of uterus, except cervix

211

820

1.75

12.26

1.3

1.2

0.34

0.21

nmol/l

0.43

Other congenital malformations

120

591

2.05

12.19

2.1

1.2

0.16

0.38

nmol/l

1.12

Adhesive capsulitis of shoulder

157

849

1.87

12.14

1.3

0.15

0.26

nmol/l

—

Deforming dorsopathies

238

1448

1.65

12.14

1.2

0.23

0.20

nmol/l

0.16

Malignant neoplasm of small intestine, including Hilmo

125

3.45

12.00

1.2

0.12

0.51

nmol/l

—

Certain disorders involving the immune mechanism

181

1028

1.78

11.93

1.2

1.3

0.24

0.25

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

321

1653

1.55

11.92

1.3

0.21

0.29

nmol/l

0.76

136

Specific personality disorders

212

1258

1.70

11.92

1.2

0.14

0.26

nmol/l

1.69

Other retinal disorders

544

3051

1.39

11.91

1.3

0.16

0.26

nmol/l

1.99

232

Venous thromboembolism

458

3108

1.43

11.90

1.3

0.17

0.26

nmol/l

1.61

225

Other specified/unspecified arthritis

238

1456

1.65

11.89

1.2

1.3

0.20

0.28

nmol/l

0.37

100

Oxicams

181

565

1.83

11.87

1.3

0.27

0.25

nmol/l

—

Irregular menses

425

2316

1.46

11.83

1.2

1.3

0.25

0.21

nmol/l

0.14

119

Artrosis, including avohilmo

712

2904

1.35

11.80

1.3

0.15

0.23

nmol/l

1.60

202

Nontoxic multinodular goitre

190

1099

1.74

11.76

1.3

0.32

0.25

nmol/l

0.15

Septicaemia

345

2150

1.51

11.75

1.4

1.3

0.19

0.28

nmol/l

0.98

153

Artificial joint operation, meniscal resection

793

3919

1.32

11.72

1.2

1.3

0.27

0.23

nmol/l

0.15

273

Fenamates

129

437

2.02

11.71

1.4

1.2

0.18

0.26

nmol/l

—

COPD, hospital admissions

365

2075

1.49

11.71

1.3

0.17

0.28

nmol/l

1.55

166

Injuries to the abdomen, lower back, lumbar spine and pelvis

336

2209

1.51

11.68

1.2

1.3

0.27

0.25

nmol/l

0.09

144

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

219

1312

1.67

11.67

1.3

0.17

0.25

nmol/l

0.82

COPD, early/later onset

368

2091

1.49

11.65

1.3

0.17

0.28

nmol/l

1.55

166

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

493

3427

1.40

11.59

1.2

1.3

0.29

0.22

nmol/l

0.52

203

Neuromuscular dysfunction of bladder

425

2.22

11.54

1.3

0.37

0.28

nmol/l

—

Diseases of pulp and periapical tissues and dental caries

564

2079

1.39

11.49

1.3

0.27

0.26

nmol/l

0.02

153

Dental caries, including avohilmo

638

2397

1.37

11.47

1.3

0.23

0.27

nmol/l

0.29

173

Thoracic aortic aneurysm

118

592

2.01

11.44

1.3

0.12

0.31

nmol/l

—

Dental operations

533

1954

1.41

11.40

1.3

0.22

0.29

nmol/l

0.45

151

Non-ischemic cardiomyopathy

250

1251

1.62

11.35

1.3

0.19

0.35

nmol/l

1.10

Trochanteric bursitis

138

733

1.90

11.33

1.2

1.3

0.29

nmol/l

0.01

Benign neoplasm of urinary organs

205

2.79

11.23

1.4

1.3

0.22

0.43

nmol/l

—

Psychotic depression

239

2.63

11.21

1.5

1.3

0.14

0.28

nmol/l

—

Asthma-related pneumonia

299

1953

1.54

11.21

1.3

0.16

0.26

nmol/l

1.62

137

Other acute lower respiratory infections

433

2901

1.43

11.21

1.3

0.15

0.24

nmol/l

2.46

187

Restless leg syndrome

131

687

1.93

11.20

1.3

0.57

0.32

nmol/l

—

Benign neoplasm: Rectum, anus and anal canal

181

1048

1.74

11.18

1.5

1.3

0.14

0.25

nmol/l

1.39

Other specified/unspecified soft tissue disorders

200

2.80

11.16

1.3

—

0.47

nmol/l

—

Temporomandibular joint disorders, including avohilmo

387

2633

1.46

11.15

1.3

0.13

0.22

nmol/l

2.42

139

Asthma, hospital admissions 3, pneumonia

299

1956

1.53

11.13

1.3

0.16

0.26

nmol/l

1.62

137

Asthma-related pneumonia or sepsis

299

1956

1.53

11.13

1.3

0.16

0.26

nmol/l

1.62

137

Nonalcoholic fatty liver disease

104

504

2.09

11.13

1.3

0.19

0.34

nmol/l

—

Allergic conjunctivitis

514

3634

1.38

11.11

1.2

1.3

0.29

0.21

nmol/l

0.54

212

Caries of dentine, including avohilmo

678

2583

1.35

11.08

1.3

0.24

0.26

nmol/l

0.16

182

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

318

2105

1.51

11.06

1.3

0.21

0.24

nmol/l

0.11

102

Combinations of oral blood glucose lowering drugs

230

1424

1.63

11.00

1.3

0.17

0.27

nmol/l

1.16

110

Other diseases of blood and blood-forming organs, wide

197

1173

1.69

10.99

1.4

1.3

0.15

0.27

nmol/l

1.65

Viral infections characterized by skin and mucous membrane lesions

739

4834

1.31

10.99

1.3

0.15

0.25

nmol/l

3.02

310

Primary gonarthrosis, bilateral

434

2620

1.43

10.95

1.2

1.3

0.16

0.24

nmol/l

1.87

214

Missing teeth due to accident, extraction or parodontitis

516

3545

1.38

10.80

1.3

0.23

0.24

nmol/l

0.07

253

Inflammatory disease of uterus

134

718

1.88

10.74

1.2

0.12

0.28

nmol/l

—

Mycoses

731

4880

1.31

10.66

1.3

0.25

0.23

nmol/l

0.12

304

Other inflammation of eyelid

130

692

1.90

10.64

1.3

0.17

0.32

nmol/l

—

Other arthritis (FG)

269

1743

1.55

10.61

1.2

1.3

0.20

0.26

nmol/l

0.33

120

Other and unspecified disorders of vitreous body

376

2574

1.45

10.56

1.2

1.3

0.18

0.26

nmol/l

0.91

200

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

448

2.13

10.53

1.2

1.3

0.10

0.36

nmol/l

—

Other and unspecified drugs and medicaments

403

2.19

10.49

1.2

1.3

0.10

0.40

nmol/l

—

Other postsurgical states

278

2.45

10.43

1.7

1.3

—

0.27

—

Dentofacial anomalies [including malocclusion]

609

3669

1.34

10.38

1.3

0.14

0.24

nmol/l

3.22

205

Neuralgia and neuritis, unspecified

220

2.63

10.34

1.2

1.3

0.54

0.51

nmol/l

—

Type 1 diabetes

197

1191

1.66

10.32

1.4

1.2

0.14

0.31

nmol/l

1.55

Exposure to other specified factors

641

4462

1.32

10.31

1.3

0.21

0.25

nmol/l

0.33

275

Other disorders of white blood cells

227

2.60

10.24

1.2

0.16

0.39

nmol/l

—

Benign neoplasm: Transverse colon

103

514

2.03

10.22

1.4

1.3

0.30

0.34

nmol/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

178

1054

1.70

10.18

1.2

1.3

0.25

nmol/l

0.01

Procreative management

294

1627

1.51

10.13

1.8

1.3

0.16

0.23

nmol/l

0.83

101

Dislocation, sprain and strain of joints and ligaments at neck level

134

732

1.85

10.13

1.2

1.3

0.12

0.32

nmol/l

—

Ischaemic Stroke, excluding all haemorrhages

461

2471

1.39

10.10

1.3

0.24

0.25

nmol/l

0.09

196

Menorrhagia

294

1067

1.54

10.07

1.3

0.20

nmol/l

0.00

Retention of urine

249

1309

1.57

10.05

1.3

0.39

0.27

nmol/l

0.34

116

Other disorders of bone

178

1059

1.69

10.01

1.3

1.2

0.18

0.26

nmol/l

0.54

Peripheral artery disease

333

1807

1.47

9.98

1.3

0.20

0.29

nmol/l

0.90

146

Chronic laryngitis and laryngotracheitis

126

679

1.87

9.96

1.2

1.3

0.19

0.26

nmol/l

—

Conjunctivitis (acute, non atopic)

242

1549

1.57

9.95

1.3

0.16

0.23

nmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

263

1721

1.54

9.94

1.4

1.3

0.18

0.26

nmol/l

1.02

130

Cardiac murmurs and other cardiac sounds

330

2.27

9.93

1.6

1.3

0.18

0.37

nmol/l

—

Disorders of choroid and retina

679

3692

1.31

9.91

1.3

0.21

0.24

nmol/l

0.45

265

Intestinal adhesions without obstruction

336

2.26

9.82

1.4

1.3

0.12

0.31

nmol/l

—

Benign neoplasm: Rectum

161

938

1.73

9.81

1.4

1.3

0.15

0.26

nmol/l

1.27

Superficial injury of lower leg

216

1357

1.60

9.79

1.2

1.3

0.18

0.24

nmol/l

0.55

Benign neoplasm: Stomach

101

510

2.01

9.73

1.4

1.3

0.37

0.35

nmol/l

0.05

Other shoulder lesions

442

2.08

9.73

1.2

1.3

0.13

0.40

nmol/l

—

Other diseases of blood and blood-forming organs

313

2.30

9.69

1.4

1.3

0.18

0.35

nmol/l

—

Fissure and fistula of anal and rectal regions

191

1168

1.65

9.67

1.2

1.3

0.12

0.25

nmol/l

1.77

Other bacterial intestinal infections

192

1178

1.64

9.60

1.3

0.24

0.22

nmol/l

0.07

Sicca syndrome [Sjögren]

459

2.05

9.56

1.3

1.2

0.16

0.43

nmol/l

—

COPD-related respiratory insufficiency

472

2.03

9.55

1.4

1.3

0.20

0.32

nmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

268

1778

1.52

9.54

1.4

1.2

0.15

0.26

nmol/l

1.50

118

Disorders of lens

568

2654

1.34

9.50

1.3

0.26

0.22

nmol/l

0.19

203

Metatarsalgia

461

2.04

9.43

1.2

1.3

0.31

0.40

nmol/l

—

Lateral epicondylitis

122

663

1.86

9.42

1.2

1.3

0.13

0.30

nmol/l

—

Otalgia

362

2.18

9.40

1.4

1.3

0.12

0.43

nmol/l

—

Symptoms and signs involving speech and voice

291

1970

1.49

9.40

1.3

0.17

0.22

nmol/l

0.95

138

Other enthesopathy of foot (+metatarsalgia)

496

2.00

9.37

1.2

1.3

0.31

0.40

nmol/l

—

Asthma and allergy, excluding more controls

106

543

1.94

9.37

1.2

1.3

0.28

0.30

nmol/l

—

Leiomyoma of uterus

567

2405

1.34

9.36

1.3

1.2

0.38

0.19

nmol/l

1.08

141

Diseases of external ear

280

1883

1.50

9.34

1.3

0.22

0.25

nmol/l

0.17

131

Other and unspecified visual disturbances

485

2.00

9.24

1.3

0.17

0.33

nmol/l

—

Chronic periodontitis, complicated

463

3382

1.36

9.22

1.3

0.18

0.25

nmol/l

1.14

242

Other bacterial intestinal infections

151

881

1.73

9.17

1.3

0.22

0.24

nmol/l

0.07

Voice disturbances

236

1538

1.54

9.17

1.3

0.16

0.24

nmol/l

1.03

106

Other abnormal uterine and vaginal bleeding

199

882

1.63

9.14

1.2

0.19

0.21

nmol/l

—

Asthma and allergy

106

548

1.92

9.13

1.2

1.3

0.28

0.25

nmol/l

—

Gout, strict definition

137

779

1.77

9.11

1.3

0.14

0.29

nmol/l

1.19

Liquid cancers, helper endpoint

299

1779

1.47

9.11

1.4

1.2

0.17

0.26

nmol/l

1.53

129

Other disorders of eyelid

367

2482

1.41

9.10

1.2

1.3

0.19

0.26

nmol/l

0.68

207

Gout, FINNGEN

216

1378

1.57

9.09

1.2

1.3

0.23

0.30

nmol/l

0.30

119

COPD, hospital admission 2, with asthma infections

238

1328

1.54

9.07

1.3

0.19

0.32

nmol/l

1.00

105

Cellulitis

185

1142

1.63

9.07

1.2

1.3

0.20

0.23

nmol/l

0.22

Cerebral aneurysm, nonruptured

441

2.04

9.06

1.6

1.2

0.16

0.33

nmol/l

—

Other diseases of oesophagus

401

2.09

9.02

1.3

0.13

0.29

nmol/l

1.40

Pulmonary embolism

241

1583

1.53

9.01

1.4

1.3

0.18

0.27

nmol/l

0.93

119

Triptan medication for migraine, min. 3 purchases

483

2729

1.36

9.01

1.3

0.15

0.23

nmol/l

1.90

148

Pulmonary heart disease

241

1584

1.53

8.99

1.4

1.3

0.18

0.27

nmol/l

0.91

120

Heart failure and bmi 25plus

304

1399

1.48

8.97

1.3

0.15

0.28

nmol/l

1.28

102

Postprocedural disorders of nervous system

311

2.25

8.95

1.3

0.14

0.56

nmol/l

—

Laparoscopic right hemicolectomy

255

2.39

8.95

1.3

1.2

0.42

0.44

nmol/l

—

Hernia of abdominal wall

376

2695

1.40

8.93

1.3

0.14

0.26

nmol/l

2.37

201

Cerebral palsy and other paralytic syndromes

100

519

1.95

8.91

1.3

0.29

0.36

nmol/l

—

Diseases of the myoneural junction and muscle

109

583

1.89

8.88

1.5

1.3

0.42

0.31

nmol/l

0.17

Gingival hyperplasia

134

2.97

8.86

1.6

1.3

0.15

0.53

nmol/l

—

Gout, idiopatic and unspecified

185

1149

1.62

8.85

1.3

0.24

0.32

nmol/l

0.28

100

Congenital malformations of the urinary system

250

2.39

8.84

1.4

1.3

0.32

0.37

nmol/l

—

Glomerulonephritis

446

2.02

8.79

1.2

1.3

0.10

0.36

nmol/l

—

Benign neoplasm: Colon, unspecified

209

1339

1.57

8.78

1.3

0.20

0.26

nmol/l

0.35

105

Presence of cardiac and vascular implants and grafts

341

1778

1.43

8.76

1.3

0.21

0.26

nmol/l

0.31

162

Spondylolisthesis/Spondylolysis

154

916

1.69

8.74

1.2

1.3

0.22

0.21

nmol/l

0.05

Appendectomy

553

4034

1.31

8.67

1.3

0.16

0.23

nmol/l

1.28

242

Cystic kidney disease

125

3.02

8.67

1.5

1.3

0.32

0.63

nmol/l

—

Bipolar affective disorders

159

956

1.67

8.66

1.2

1.3

0.18

0.30

nmol/l

1.10

Abnormal results of function studies

409

2.05

8.60

1.7

1.3

0.30

nmol/l

—

Appendicitis, broad definition

619

4341

1.29

8.55

1.2

1.3

0.23

0.24

nmol/l

0.08

279

Diseases of appendix

626

4382

1.29

8.53

1.2

1.3

0.23

0.24

nmol/l

0.07

281

Special screening examination for infectious and parasitic diseases

167

742

1.66

8.52

1.3

0.13

0.31

nmol/l

—

Contact with and exposure to communicable diseases

243

1612

1.51

8.51

1.3

0.23

nmol/l

0.04

Budesonide

125

707

1.78

8.51

1.3

0.20

0.35

nmol/l

0.75

Haemorrhage, not elsewhere classified

121

3.02

8.49

1.3

1.2

0.18

0.20

nmol/l

0.13

Gout, unspecified

153

916

1.68

8.49

1.3

0.24

0.38

nmol/l

0.38

Emotionally unstable personality disorder

103

550

1.89

8.44

1.1

1.3

0.10

0.28

nmol/l

—

Other viral diseases

301

2083

1.44

8.36

1.2

1.3

0.15

0.23

nmol/l

1.33

111

Necrosis of pulp, including avohilmo

479

3595

1.33

8.36

1.2

1.3

0.26

0.24

nmol/l

0.13

216

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

190

2.57

8.35

1.4

1.3

0.18

0.45

nmol/l

—

Colectomy operation

144

855

1.70

8.27

1.4

1.3

0.34

0.26

nmol/l

—

Internal derangement of knee

297

2061

1.44

8.26

1.3

0.20

0.28

nmol/l

0.66

137

Oter anti-inflammatory and antirheumatic agents, non-steroids

159

519

1.70

8.25

1.2

1.3

0.23

0.24

nmol/l

0.04

Mental disorders, not otherwise specified

389

2.05

8.22

1.2

1.3

0.15

0.43

nmol/l

—

Other diseases of lip and oral mucosa

345

2476

1.40

8.19

1.3

0.17

0.21

nmol/l

0.40

169

Viral infections of the central nervous system

343

2.12

8.18

1.4

1.3

0.15

0.38

nmol/l

—

Spondyloarthritis

143

850

1.69

8.16

1.3

0.13

0.29

nmol/l

—

Acute appendicitis

580

4200

1.29

8.12

1.2

1.3

0.23

0.24

nmol/l

0.08

270

Senile cataract

512

2370

1.33

8.11

1.3

0.27

0.23

nmol/l

0.20

183

Vitamin deficiency, wide

187

2.55

8.10

1.3

1.2

0.18

0.31

nmol/l

—

Vitamin deficiency

187

2.55

8.10

1.3

1.2

0.18

0.31

nmol/l

—

Congenital malformations of the urinary system

236

2.36

8.05

1.4

1.3

0.32

0.37

nmol/l

—

Emphysema

255

2.30

8.02

1.6

1.3

0.24

0.40

nmol/l

—

Coxarthrosis

391

1879

1.38

8.01

1.3

0.17

0.26

nmol/l

1.37

149

Familial hypercholesterolemia

109

603

1.82

8.01

1.4

1.3

0.14

0.34

nmol/l

1.39

Deviated nasal septum

257

1756

1.47

7.95

1.3

0.16

0.27

nmol/l

1.63

132

Cystic kidney disease

137

2.83

7.95

1.5

1.3

0.32

0.54

nmol/l

—

Otitis externa, unspecified

521

1.88

7.85

1.4

1.3

0.19

0.35

nmol/l

—

Diabetic nephropathy

151

909

1.66

7.85

1.3

0.16

0.24

nmol/l

0.56

Atopic dermatitis

478

2964

1.33

7.85

1.3

0.29

0.22

nmol/l

0.23

175

Sequelae of cerebrovascular disease

267

1586

1.46

7.82

1.3

0.14

0.30

nmol/l

1.80

119

Endometriosis of ovary

145

854

1.67

7.81

1.3

0.25

0.21

nmol/l

—

Early onset COPD

180

1150

1.58

7.72

1.2

1.3

0.15

0.27

nmol/l

1.26

Gonarthrosis, primary, with knee surgery

462

2776

1.33

7.72

1.2

1.3

0.32

0.24

nmol/l

0.21

225

Diabetic nephropathy, excluding more controls

148

738

1.67

7.68

1.3

1.4

0.16

0.27

nmol/l

0.57

Chronic diseases of tonsils and adenoids

656

3264

1.27

7.68

1.3

0.23

nmol/l

0.00

191

Dialysis

140

2.76

7.64

1.2

1.3

0.30

0.44

nmol/l

—

Alcohol use disorder, Swedish definition

422

2895

1.34

7.62

1.2

1.3

0.15

0.27

nmol/l

2.40

189

Mental and behavioural disorders due to alcohol, excluding acute intoxication

341

2462

1.38

7.60

1.2

1.3

0.15

0.27

nmol/l

1.98

161

Iron deficiency anaemia secondary to blood loss (chronic)

130

770

1.70

7.57

1.3

0.13

0.25

nmol/l

1.48

Female genital prolapse

248

945

1.49

7.55

1.3

0.14

0.20

nmol/l

—

Injuries to the thorax

353

2578

1.37

7.54

1.3

0.34

0.26

nmol/l

0.34

187

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

268

2.22

7.54

1.2

0.26

0.29

nmol/l

—

Aneurysms, operations, SAH

137

824

1.68

7.53

1.5

1.3

0.15

0.27

nmol/l

1.22

Delirium, not induced by alcohol and other psychoactive substances

492

1.88

7.51

1.3

0.36

0.34

nmol/l

0.06

Paracetamol or NSAID medication

111

304

1.85

7.49

1.3

1.2

0.44

0.20

nmol/l

—

Peripheral arterial reconstruction

119

691

1.73

7.44

1.3

0.19

0.30

nmol/l

1.11

Type 1 diabetes, wide definition, subgroup 1

159

995

1.61

7.42

1.3

1.2

0.14

0.29

nmol/l

—

Mental and behavioural disorders due to alcohol

388

2770

1.35

7.42

1.2

1.3

0.15

0.27

nmol/l

2.26

179

Bacterial intestinal infections, IBD co-morbidities

145

890

1.64

7.37

1.3

0.22

0.21

nmol/l

0.04

Injury of unspecified body region

331

2.08

7.34

1.5

1.3

0.13

0.37

nmol/l

—

Non-allergic asthma (mode), excluding more controls

143

867

1.64

7.32

1.3

1.2

0.16

0.27

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

463

1.90

7.28

1.4

1.3

0.13

0.32

nmol/l

—

445

3053

1.32

7.28

1.2

1.3

0.15

0.27

nmol/l

2.46

196

Benign neoplasm: Caecum

528

1.84

7.26

1.3

0.12

0.31

nmol/l

—

Acute appendicitis, no complications

452

3431

1.32

7.25

1.2

1.3

0.23

nmol/l

0.05

207

Vascular diseases of the intestine

127

2.79

7.24

1.2

1.3

0.40

0.51

nmol/l

—

Disorders of sclera, cornea, iris and ciliary body

449

3425

1.32

7.21

1.2

1.3

0.30

0.23

nmol/l

0.27

230

Other disorders of breast

123

729

1.70

7.19

1.2

0.28

0.30

nmol/l

—

Other menopausal disorders

239

911

1.49

7.18

1.3

0.14

0.20

nmol/l

0.73

DVT of lower extremities and pulmonary embolism

326

2362

1.38

7.18

1.3

0.18

0.27

nmol/l

1.15

181

Type 1 diabetes, wide definition

164

1043

1.58

7.17

1.3

1.2

0.14

0.29

nmol/l

—

Noninflammatory disorders of female genital tract

329

1181

1.40

7.16

1.2

1.3

0.23

0.20

nmol/l

0.16

Other diseases of pleura

336

2149

1.38

7.14

1.3

0.21

0.28

nmol/l

0.53

169

Impingement syndrome of shoulder

193

1276

1.52

7.13

1.3

0.29

0.28

nmol/l

—

Other and unspecified disorders of white blood cells

163

2.56

7.13

1.2

0.16

0.46

nmol/l

—

Other dialysis

102

2.99

7.00

1.2

1.4

0.20

0.35

nmol/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

194

1290

1.51

6.99

1.3

0.15

0.25

nmol/l

1.52

Other female pelvic inflammatory diseases

152

958

1.60

6.98

1.3

1.2

0.22

0.27

nmol/l

—

Monoamine oxidase A inhibitors

106

608

1.76

6.98

1.4

1.3

0.14

0.28

nmol/l

—

Vasomotor and allergic rhinitis

296

2092

1.39

6.94

1.2

1.3

0.21

0.24

nmol/l

0.21

111

Superficial injury of wrist and hand

167

1077

1.56

6.93

1.3

0.48

0.25

nmol/l

—

Achilles tendinitis

472

1.86

6.89

1.2

1.3

0.10

0.27

nmol/l

—

Abnormal serum enzyme levels

208

1371

1.49

6.87

1.3

0.15

0.30

nmol/l

1.91

121

Otitis externa

181

1193

1.53

6.81

1.3

1.2

0.28

0.26

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

186

1048

1.52

6.81

1.3

0.15

0.35

nmol/l

1.70

Other and unspecified tonsillitis

251

1477

1.43

6.78

1.4

1.3

0.27

0.21

nmol/l

0.28

Postmenopausal bleeding

229

828

1.48

6.78

1.1

1.3

0.15

0.20

nmol/l

0.85

N06DA Anticholinesterases

100

1345

0.58

6.70

1.4

1.3

0.39

0.34

nmol/l

—

100

Use of anticholinesterases

100

1345

0.58

6.70

1.4

1.3

0.39

0.34

nmol/l

—

100

Problems related to lifestyle

455

1.86

6.69

1.3

0.16

0.32

nmol/l

—

311

2081

1.38

6.68

1.3

0.18

0.28

nmol/l

1.20

165

Coxarthrosis [arthrosis of hip](FG)

428

2293

1.32

6.67

1.3

0.18

0.24

nmol/l

0.89

181

Unspecific neurodegenerative disorder

147

1566

0.64

6.66

1.3

0.28

0.31

nmol/l

0.07

126

Fracture of lower leg, including ankle

449

3429

1.30

6.65

1.2

1.3

0.21

0.26

nmol/l

0.43

219

Later onset COPD

188

995

1.51

6.60

1.4

1.3

0.18

0.34

nmol/l

1.08

Atopic dermatitis, strict definition with reimbursement

234

1577

1.44

6.57

1.2

1.3

0.39

0.24

nmol/l

—

Other blood glucose lowering drugs, excl. Insulins

124

755

1.65

6.57

1.3

0.23

0.28

nmol/l

—

463

3158

1.29

6.57

1.2

1.3

0.15

0.27

nmol/l

2.45

196

Injuries to the shoulder and upper arm

686

4479

1.24

6.55

1.3

0.16

0.25

nmol/l

2.25

290

Non-allergic asthma (mode)

143

893

1.59

6.55

1.3

0.16

0.27

nmol/l

—

Spondylopathies (FG)

117

703

1.68

6.53

1.3

1.2

0.12

0.32

nmol/l

—

Autonomic disorders

3.12

6.51

1.5

1.3

—

0.98

nmol/l

—

Disorders of continuity of bone

474

1.83

6.50

1.2

1.3

0.46

0.40

nmol/l

—

Other skin changes

144

912

1.59

6.50

1.2

1.3

0.15

0.29

nmol/l

—

Excessive attrition of teeth

450

3489

1.29

6.46

1.3

0.21

nmol/l

0.00

218

Zoster [herpes zoster]

401

3014

1.31

6.44

1.3

0.17

0.26

nmol/l

1.36

218

COPD, hospital admissions 1, only main diagnosis

246

1485

1.42

6.44

1.2

1.3

0.18

0.32

nmol/l

1.27

124

Viral pneumonia (unknown virus, not influenza)

287

2.08

6.43

1.3

0.13

0.35

nmol/l

—

Other and/or unspecified nontoxic goitre

433

1.87

6.43

1.5

1.3

0.43

0.38

nmol/l

—

Ulcer of lower limb, not elsewhere classified

111

661

1.69

6.41

1.3

0.17

0.29

nmol/l

1.11

Fracture of rib(s), sternum and thoracic spine

225

1569

1.44

6.40

1.3

0.33

0.24

nmol/l

0.30

116

Superficial injury of head

186

1250

1.50

6.40

1.2

1.3

0.31

0.26

nmol/l

0.13

Other specified/unspecified bacterial intestinal infections

309

2.03

6.35

1.5

1.3

0.12

0.37

nmol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

309

2.03

6.34

1.4

1.3

0.14

0.35

nmol/l

—

Benign neoplasm: Sigmoid colon

154

998

1.55

6.31

1.5

1.3

0.17

0.26

nmol/l

0.87

Mycoses

211

1462

1.45

6.23

1.3

0.29

0.25

nmol/l

0.19

Candidiasis

113

682

1.67

6.22

1.3

0.34

0.32

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

484

3504

1.28

6.20

1.2

1.3

0.15

0.24

nmol/l

2.69

210

Degeneration of macula and posterior pole

366

2200

1.33

6.20

1.3

0.15

0.28

nmol/l

2.09

177

Vitamin B12 deficiency anaemia

460

1.82

6.18

1.3

0.51

0.33

nmol/l

—

All influenza

189

1284

1.48

6.17

1.5

1.3

0.18

0.26

nmol/l

0.78

Ménière disease

469

1.81

6.12

1.4

1.3

0.16

0.36

nmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

134

822

1.59

6.10

1.5

1.2

0.29

nmol/l

—

Persistent mood disorders

157

1030

1.53

6.09

1.3

0.16

0.29

nmol/l

1.57

Superficial injury of ankle and foot

528

1.75

6.09

1.3

0.40

0.36

nmol/l

—

Any dementia

131

1423

0.64

6.08

1.3

0.21

0.32

nmol/l

0.69

106

Propionic acid derivatives

193

648

1.50

6.08

1.3

0.43

0.25

nmol/l

—

Preparatory care for dialysis

164

2.41

6.07

1.3

0.19

0.48

nmol/l

—

Viral and other specified intestinal infections

200

1330

1.46

6.04

1.3

0.14

0.25

nmol/l

—

Viral infections of the central nervous system

323

1.97

5.98

1.4

1.3

0.15

0.39

nmol/l

—

Viral pneumonia

103

614

1.69

5.96

1.3

0.17

0.33

nmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

289

1962

1.36

5.95

1.3

0.18

0.30

nmol/l

1.12

151

Rash and other nonspecific skin eruption

474

1.79

5.92

1.3

0.26

0.40

nmol/l

—

Superficial injury of abdomen, lower back and pelvis

118

730

1.63

5.91

1.3

0.13

0.33

nmol/l

—

Alzheimer disease, including avohilmo

116

1302

0.62

5.89

1.4

1.3

0.12

0.32

nmol/l

—

Crohn's disease NAS

277

2.04

5.88

1.3

0.16

0.37

nmol/l

—

Diseases of male genital organs

344

1295

1.34

5.87

1.3

1.4

0.11

0.27

nmol/l

2.02

104

Other viral diseases, not elsewhere classified

205

1422

1.44

5.86

1.3

0.13

0.24

nmol/l

—

Alzheimer disease

1112

0.59

5.83

1.3

0.13

0.28

nmol/l

—

Acute pharyngitis

112

681

1.64

5.81

1.4

1.3

0.12

0.24

nmol/l

—

Other medical care

350

2394

1.32

5.77

1.4

1.3

0.34

0.22

nmol/l

0.32

177

Duodenal ulcer

412

1.83

5.77

1.4

1.2

0.43

0.28

nmol/l

0.23

Hyperplasia of prostate

226

899

1.43

5.76

1.4

1.3

0.12

0.28

nmol/l

1.62

Kidney transplant status

200

2.23

5.74

1.5

1.4

0.30

0.34

nmol/l

—

Alzheimer’s disease, strict definition

927

0.53

5.74

1.5

1.3

0.12

0.29

nmol/l

—

Calcific aortic valvular stenosis, operated

195

1313

1.45

5.70

1.2

1.3

0.26

0.32

nmol/l

0.21

113

Calcific aortic valvular stenosis

195

1313

1.45

5.70

1.2

1.3

0.26

0.32

nmol/l

0.21

113

L04AA Selective immunosuppressants

184

1266

1.46

5.69

1.3

0.22

0.23

nmol/l

—

Focal epilepsy

160

1070

1.50

5.69

1.3

0.18

0.26

nmol/l

0.67

Actinic keratosis

277

1891

1.36

5.67

1.3

0.13

0.30

nmol/l

2.63

147

Trigeminal neuralgia

261

2.05

5.65

1.3

0.14

0.46

nmol/l

—

Car occupant injured in other and unspecified transport accidents

148

976

1.52

5.65

1.3

0.13

0.29

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

226

1618

1.40

5.61

1.4

1.3

0.18

0.26

nmol/l

1.07

Polymyalgia rheumatica

103

625

1.66

5.61

1.2

1.3

0.10

0.28

nmol/l

—

Thiazolidinediones

498

1.74

5.57

1.2

0.17

0.35

nmol/l

—

204

1247

1.43

5.56

1.3

0.15

0.33

nmol/l

1.56

Other respiratory disorders and diseases

143

940

1.53

5.54

1.4

1.3

0.17

0.28

nmol/l

1.18

Other diseases of the respiratory system

143

940

1.53

5.54

1.4

1.3

0.17

0.28

nmol/l

1.18

Focal epilepsy, mode (most common among epilepsy diagnosis)

141

924

1.53

5.54

1.3

0.19

0.27

nmol/l

0.57

Alcohol use disorder, ICD-based

305

2295

1.33

5.53

1.2

1.3

0.16

0.28

nmol/l

1.76

151

Operations 2 for CAVS

194

1313

1.44

5.53

1.2

1.3

0.26

0.32

nmol/l

0.21

113

Calcific aortic valvular stenosis, diagnosis (helper)

194

1313

1.44

5.53

1.2

1.3

0.26

0.32

nmol/l

0.21

113

Excessive earwax

424

3252

1.28

5.52

1.3

0.30

0.24

nmol/l

0.40

232

Unspecified fall

386

2956

1.29

5.50

1.2

1.3

0.22

0.24

nmol/l

0.09

200

ILD medications: azathioprine

117

737

1.60

5.48

1.4

1.2

0.29

0.34

nmol/l

—

Postmenopausal atrophic vaginitis

219

850

1.43

5.48

1.2

1.3

0.24

0.20

nmol/l

—

Impotence

185

2.24

5.46

1.3

1.4

0.14

0.30

nmol/l

—

Use of pramipexole

178

1228

1.46

5.46

1.2

1.3

0.47

0.23

nmol/l

1.34

Dementia

169

1687

0.69

5.44

1.3

0.29

0.28

nmol/l

0.03

132

Other disorders of the musculoskeletal system and connective tissue

121

770

1.58

5.44

1.2

1.3

0.39

0.29

nmol/l

0.22

In situ neoplasms

293

2200

1.34

5.41

1.3

0.14

0.26

nmol/l

2.81

152

Calcific aortic valvular stenosis, including rheumatic fever

194

1318

1.43

5.40

1.2

1.3

0.26

0.32

nmol/l

0.21

113

Thyrotoxicosis with diffuse goitre

115

725

1.60

5.38

1.2

1.3

0.29

0.30

nmol/l

—

Diseases of peritoneum

489

1.73

5.36

1.4

1.3

0.20

0.36

nmol/l

0.83

Dementia, including avohilmo

187

1825

0.70

5.34

1.3

0.29

nmol/l

0.01

145

Alzheimer’s disease (Late onset)

847

0.52

5.33

1.4

1.3

0.12

0.27

nmol/l

—

Focal epilepsy, strict definition

147

981

1.51

5.32

1.3

0.19

0.27

nmol/l

0.59

Other and unspecified myopathies

373

1.84

5.30

1.3

0.51

0.33

nmol/l

—

Cholecystitis

100

612

1.64

5.28

1.3

0.17

0.30

nmol/l

—

Periapical abscess

355

2748

1.30

5.27

1.2

1.3

0.29

0.22

nmol/l

0.35

177

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

124

774

1.56

5.26

1.5

1.3

0.31

nmol/l

—

Poisoning by drugs, medicaments and biological substances

185

1296

1.43

5.23

1.3

1.2

0.14

0.27

nmol/l

1.80

Benign leiomyoma with endometriosis

146

979

1.50

5.21

1.3

0.50

0.24

nmol/l

—

Tuberous sclerosis 1

14.69

5.20

2.1

1.7

—

Other orthopaedic follow-up care

256

2.01

5.19

1.3

0.15

0.41

nmol/l

—

Other specified and unspecified personality disorders

405

1.79

5.18

1.2

1.3

0.13

0.40

nmol/l

—

Azathioprine

117

749

1.57

5.15

1.4

1.2

0.29

0.34

nmol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

239

1755

1.37

5.13

1.3

0.27

0.20

nmol/l

0.21

107

Any death

334

3088

0.77

5.08

1.3

0.39

0.22

nmol/l

0.59

222

Sub-endpoint used in defining T1D endpoints

209

1480

1.39

5.06

1.4

1.3

0.14

0.24

nmol/l

1.78

Coagulation defects, purpura and other haemorrhagic conditions

145

977

1.49

5.04

1.3

0.28

0.27

nmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

372

1.82

5.04

1.1

1.3

0.11

0.39

nmol/l

—

Acute pancreatitis

143

961

1.50

5.04

1.2

1.3

0.19

0.25

nmol/l

0.60

Radial styloid tenosynovitis [de Quervain]

246

2.01

5.00

1.3

0.10

0.49

nmol/l

—

Other peripheral vertigo

462

1.73

4.99

1.3

0.12

0.35

nmol/l

—

L04AD Calcineurin inhibitors

530

1.67

4.98

1.3

0.22

0.33

nmol/l

—

Polyp of the female genital tract

240

1005

1.38

4.97

1.2

1.3

0.13

0.20

nmol/l

1.16

Traumatic subdural haemorrhage

458

1.71

4.93

1.1

1.3

0.14

0.21

nmol/l

—

Crohn disease

100

626

1.61

4.86

1.2

1.3

0.17

0.33

nmol/l

—

Atopic dermatitis, strict definition

219

1568

1.37

4.85

1.2

0.46

0.23

nmol/l

—

Ovarian dysfunction

263

1.95

4.82

1.2

1.1

—

0.44

nmol/l

—

Fracture of skull and facial bones

163

1135

1.44

4.81

1.3

0.32

0.25

nmol/l

0.32

Lesion of ulnar nerve

106

675

1.58

4.80

1.3

0.13

0.27

nmol/l

—

Fracture of foot, except ankle

187

1335

1.41

4.80

1.2

1.3

0.18

0.24

nmol/l

0.63

Myocardial infarction, unclassifiable

134

799

1.50

4.79

1.4

1.3

0.20

0.27

nmol/l

—

Zoster [herpes zoster]

141

956

1.48

4.78

1.3

0.14

0.26

nmol/l

—

Benign lipomatous neoplasm

232

1719

1.36

4.75

1.3

0.16

0.23

nmol/l

1.01

124

Diabetes insipidus

4.82

4.73

1.6

1.2

—

nmol/l

—

Barrett oesophagus

177

2.17

4.73

1.1

1.3

0.20

0.31

nmol/l

—

Disorders of breast

411

2980

1.26

4.72

1.3

1.2

0.24

0.22

nmol/l

0.10

159

Colonic or urogenital fistula

206

1500

1.38

4.71

1.2

1.3

0.12

0.24

nmol/l

2.96

105

Vulvovaginal ulceration/inflammation in other diseases

252

1.96

4.69

1.1

1.2

—

0.45

—

Misadventures to patients during surgical and medical care

110

711

1.56

4.68

1.5

1.3

0.24

0.32

nmol/l

—

Nontraumatic intracranial haemmorrhage

138

938

1.48

4.62

1.4

1.3

0.11

0.24

nmol/l

—

Leisure time condition

136

923

1.48

4.61

1.2

1.3

0.17

0.28

nmol/l

—

Pre-eclampsia or poor fetal growth

232

1722

1.35

4.59

1.2

1.3

0.20

0.24

nmol/l

—

Trigger finger

111

723

1.54

4.58

1.2

1.3

0.13

0.31

nmol/l

—

Fracture of lumbar spine and pelvis

157

1096

1.44

4.55

1.2

1.3

0.19

0.26

nmol/l

0.77

Poisoning by medicine

165

1165

1.42

4.54

1.3

0.14

0.27

nmol/l

1.63

Respiratory insufficiency

297

1.86

4.51

1.7

1.3

0.18

0.38

nmol/l

—

Medical abortion

526

2334

1.23

4.51

1.3

1.2

0.13

0.23

nmol/l

3.15

130

Nontoxic single thyroid nodule

364

1.77

4.50

1.3

0.22

0.42

nmol/l

—

Conductive and sensorineural hearing loss

616

3465

1.20

4.50

1.3

0.28

0.23

nmol/l

0.30

247

Benign neoplasm of mouth and pharynx

538

1.63

4.49

1.4

1.3

0.19

0.35

nmol/l

—

Diabetic maculopathy, excluding more controls

454

1.68

4.47

1.2

0.22

0.36

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

219

1625

1.35

4.46

1.3

1.2

0.17

0.23

nmol/l

0.61

Peritonsillar abscess

152

1061

1.44

4.46

1.2

1.3

0.17

0.23

nmol/l

—

Blepharochalasis

231

1730

1.34

4.44

1.2

1.3

0.24

0.26

nmol/l

—

145

Amiodarone users

418

1.71

4.42

1.4

1.3

0.15

0.31

nmol/l

—

Viral infections characterized by skin and mucous membrane lesions

318

2486

1.28

4.42

1.3

0.12

0.25

nmol/l

3.92

165

Type of accident

219

1628

1.35

4.42

1.2

1.3

0.15

0.21

nmol/l

1.16

101

Scoliosis

344

1.79

4.41

1.3

0.25

0.36

nmol/l

—

Sulfonylureas

222

1311

1.35

4.40

1.4

1.3

0.18

0.28

nmol/l

1.18

106

Benign neoplasm of bone and articular cartilage

389

1.74

4.39

1.2

1.3

0.15

0.33

nmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

182

648

1.42

4.38

1.3

0.42

0.25

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

167

1191

1.41

4.36

1.3

0.21

0.27

nmol/l

0.44

Acute peritonitis

252

1.92

4.35

1.5

1.2

0.22

0.39

nmol/l

0.60

Allergic rhinitis

228

1690

1.34

4.34

1.2

1.3

0.14

0.22

nmol/l

—

Malignant neoplasm of pancreas, including Hilmo

339

1.78

4.32

1.7

1.3

0.16

0.37

nmol/l

—

Invasive ventilation

303

1.83

4.31

1.8

1.3

0.23

0.37

nmol/l

—

143

933

1.45

4.30

1.3

1.2

0.16

0.25

nmol/l

1.14

Inflammatory bowel disease

238

1799

1.33

4.30

1.3

0.21

nmol/l

0.05

106

Pre-eclampsia or eclampsia

172

1237

1.40

4.29

1.2

1.3

0.21

0.24

nmol/l

—

Other necrotizing vasculopathies (FG)

261

1.90

4.27

1.3

0.12

0.45

nmol/l

—

Degenerative diseases of the nervous system

121

1302

0.68

4.24

1.3

0.17

0.31

nmol/l

1.28

Ganglion

155

1097

1.42

4.24

1.3

0.41

0.26

nmol/l

0.36

Injuries to the wrist and hand

800

4754

1.17

4.21

1.3

0.25

0.23

nmol/l

0.10

306

Other symptoms and signs involving general sensations and perceptions

140

2.24

4.19

1.2

0.16

0.52

nmol/l

—

Haemorrhage in early pregnancy

221

1615

1.34

4.19

1.1

1.3

0.16

0.25

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

167

1185

1.40

4.18

1.7

1.2

0.53

0.30

nmol/l

0.35

Other viral diseases

213

1587

1.34

4.17

1.2

1.3

0.15

0.23

nmol/l

1.15

Olecranon bursitis

242

1.92

4.16

1.3

0.16

0.33

nmol/l

—

Spinal osteochondrosis

4.43

4.16

1.6

—

0.58

—

Familial hypercholesterolemia, with ischemic heart disease

351

1.75

4.14

1.3

0.12

0.40

nmol/l

—

Fibroblastic disorders

155

1102

1.41

4.14

1.2

1.3

0.17

0.29

nmol/l

—

Other disorders of conjunctiva

107

710

1.52

4.10

1.2

1.3

0.18

0.28

nmol/l

—

Coeliac disease

591

1.57

4.08

1.3

0.15

0.29

nmol/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

354

2811

1.25

4.07

1.3

0.31

0.20

nmol/l

0.35

167

Other benign neoplasms of skin

281

2192

1.29

4.05

1.3

0.27

0.23

nmol/l

0.13

163

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

134

933

1.44

4.04

1.5

1.2

0.59

0.33

nmol/l

0.29

Benign intracranial hypertension

3.99

4.03

1.1

1.2

—

nmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

210

1.97

4.02

1.6

1.3

—

0.17

nmol/l

—

Endocarditis

124

2.28

3.98

1.6

1.3

0.12

0.35

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

350

1894

1.26

3.98

1.3

1.2

0.19

0.25

nmol/l

0.57

143

Acne

415

1.67

3.98

1.2

1.3

—

0.38

nmol/l

—

conjunctival haemorrhage

357

1.72

3.93

1.2

1.3

0.16

0.40

nmol/l

—

Endometriosis ASRM stages 3,4

188

1394

1.35

3.92

1.2

0.24

nmol/l

—

Glaucoma

417

2934

1.23

3.91

1.3

0.18

0.26

nmol/l

1.03

227

Sensorineural hearing loss

576

3288

1.19

3.90

1.3

0.31

0.23

nmol/l

0.51

243

Acute pancreatitis (for exclusion)

143

1015

1.42

3.89

1.2

1.3

0.19

0.24

nmol/l

0.51

Cardiomyopathies, Primary/intrinsic

488

1.61

3.89

1.4

1.3

0.19

0.51

nmol/l

0.98

Fall on same level involving ice and snow

447

3692

1.21

3.87

1.3

0.27

0.24

nmol/l

0.12

244

Fentanyl

396

1.67

3.85

1.4

1.3

0.12

0.35

nmol/l

—

Alcohol-induced chronic pancreatitis

264

1.83

3.82

1.3

0.18

0.23

nmol/l

—

Iridocyclitis

169

1238

1.37

3.82

1.3

0.18

0.22

nmol/l

0.24

Papulosquamous disorders

302

2399

1.26

3.78

1.3

0.16

0.23

nmol/l

0.92

171

Unspecified mental disorder

302

2398

1.26

3.78

1.2

1.3

0.17

0.22

nmol/l

1.07

134

Traumatic subarachnoid haemorrhage

108

2.34

3.77

1.3

1.4

0.18

0.53

nmol/l

—

Complications predominantly related to the puerperium

203

1534

1.33

3.74

1.3

1.2

0.13

0.24

nmol/l

1.85

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

214

1629

1.32

3.74

1.3

0.23

nmol/l

—

Pre-eclampsia

155

1124

1.39

3.74

1.1

1.3

0.21

0.24

nmol/l

—

Artificial joint re-operation

333

1.73

3.72

1.2

1.3

0.13

0.46

nmol/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

117

809

1.45

3.68

1.2

1.3

0.26

0.28

nmol/l

—

Assault

623

1.52

3.66

1.2

1.3

0.26

0.25

nmol/l

—

Melanoma in situ

176

2.01

3.65

1.2

0.16

0.49

nmol/l

—

Infections with a predominantly sexual mode of transmission

282

2079

1.27

3.62

1.2

1.3

0.13

0.24

nmol/l

2.07

Ulcerative colitis

177

1318

1.35

3.62

1.3

0.24

nmol/l

—

Umbilical hernia

187

1404

1.34

3.62

1.2

1.3

0.14

0.30

nmol/l

1.76

Malignant neoplasm of skin

355

1969

1.24

3.60

1.3

1.2

0.22

0.25

nmol/l

0.29

145

Family history of malignant neoplasm

570

1.54

3.59

2.1

1.3

0.18

0.24

nmol/l

—

Other necrotizing vasculopathies

322

1.72

3.57

1.3

0.12

0.41

nmol/l

—

Parkinson's disease, excluding more controls

484

1.56

3.57

1.5

1.3

0.73

0.17

nmol/l

4.15

Sequelae of injuries of lower limb

445

1.61

3.55

1.4

1.3

0.14

0.36

nmol/l

—

Disorders of refraction and accommodation

198

1499

1.32

3.53

1.3

1.2

0.19

0.23

nmol/l

0.23

Scabies

661

1.49

3.53

1.2

0.12

0.34

nmol/l

—

Herpesviral [herpes simplex] infections

186

1402

1.33

3.52

1.4

1.3

0.11

0.25

nmol/l

—

Transplanted organ and tissue status

447

1.60

3.49

1.4

1.3

0.22

0.23

nmol/l

—

Pilonidal cyst

378

1.65

3.47

1.4

1.3

0.14

0.27

nmol/l

—

Diseases of middle ear and mastoid

419

2841

1.21

3.45

1.4

1.3

0.17

0.22

nmol/l

0.85

161

Infections with a predominantly sexual mode of transmission

220

1700

1.30

3.44

1.2

1.3

0.13

0.24

nmol/l

2.00

Prolonged pregnancy

659

0.57

3.44

1.3

—

0.20

nmol/l

—

Malignant melanoma

665

1.48

3.44

1.2

1.3

0.22

0.38

nmol/l

0.92

Chronic conjunctivitis

126

2.17

3.43

1.2

1.4

—

0.56

—

Fitting and adjustment of other devices

247

1750

1.28

3.42

1.2

1.3

0.35

0.24

nmol/l

0.65

137

Anterior Iridocyclitis

148

1083

1.37

3.41

1.3

0.18

0.26

nmol/l

0.53

Striking against or struck by other objects

231

1800

1.29

3.41

1.2

1.3

0.56

0.23

nmol/l

—

Ovarian dysfunction, other/unspecified

5.16

3.41

1.3

1.2

—

Intussusception

2.47

3.40

1.1

1.2

—

0.80

nmol/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

475

1.57

3.37

1.3

0.17

0.37

nmol/l

—

Keratitis

263

2088

1.26

3.36

1.3

0.36

0.22

nmol/l

0.38

139

Other hearing loss

183

1356

1.32

3.35

1.3

0.21

0.31

nmol/l

—

108

Acute and subacute iridocyclitis

140

1019

1.38

3.35

1.3

0.18

0.24

nmol/l

0.32

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

120

851

1.42

3.34

1.3

0.19

0.29

nmol/l

—

Urethritis and urethral syndrome

2.39

3.34

1.5

1.2

—

0.75

nmol/l

—

Basal cell carcinoma, including avohilmo

322

1796

1.24

3.30

1.3

1.2

0.19

0.26

nmol/l

0.58

134

Other fall from one level to another

151

1116

1.36

3.27

1.2

1.3

0.16

0.25

nmol/l

1.08

Any dementia, excluding more controls

129

1224

0.72

3.27

1.3

0.21

0.34

nmol/l

0.74

Tobacco use

212

1.86

3.27

1.1

1.3

0.17

0.33

nmol/l

—

Inflammatory diseases of prostate (prostatitis)

479

1.55

3.25

1.3

0.14

0.34

nmol/l

—

Speech therapy

196

1507

1.31

3.25

1.3

0.15

0.25

nmol/l

—

108

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

192

1454

1.31

3.25

1.4

1.2

0.12

0.25

nmol/l

—

Amenorrhoea

271

1.74

3.25

1.4

1.2

—

0.54

nmol/l

—

Methotrexate

104

723

1.45

3.24

1.2

1.3

0.24

0.33

nmol/l

—

Follicular cysts of skin and subcutaneous tissue

135

983

1.38

3.23

1.2

1.3

0.10

0.26

nmol/l

—

Graves disease, strict definition

520

1.53

3.23

1.2

1.3

0.44

0.42

nmol/l

—

Injuries to the elbow and forearm

544

4087

1.17

3.23

1.3

0.17

0.23

nmol/l

1.37

245

Other disorders of penis

379

1.62

3.19

1.2

1.3

0.22

nmol/l

—

Malignant melanoma, including Hilmo

115

817

1.41

3.19

1.2

0.21

0.33

nmol/l

0.77

Atopic conjunctivitis

186

1.90

3.16

1.1

1.4

—

0.53

nmol/l

—

Other contact dermatitis

389

1.60

3.13

1.2

1.3

0.24

0.42

nmol/l

—

Hallux rigidus

106

745

1.43

3.13

1.2

1.3

0.11

0.31

nmol/l

—

Perforation of tympanic membrane

468

1.55

3.13

1.3

0.14

0.38

nmol/l

—

Salpingitis and oophoritis

145

1075

1.36

3.12

1.2

0.23

0.25

nmol/l

—

Viral and other specified intestinal infections

134

958

1.37

3.10

1.4

1.2

0.13

0.29

nmol/l

—

Diabetes mellitus in pregnancy

215

1070

1.29

3.09

1.2

1.3

0.15

0.18

nmol/l

—

Thyroiditis

352

1.63

3.08

1.2

—

0.48

nmol/l

—

Abnormal spermatozoa

462

1.54

3.07

1.4

1.3

0.24

0.27

nmol/l

—

All influenza (not pneumonia)

101

707

1.43

3.05

1.7

1.3

0.17

0.32

nmol/l

—

Melanocytic naevi of trunk

568

1.49

3.04

1.4

1.3

0.24

0.34

nmol/l

—

Endometriosis of intestine

2.93

3.04

1.0

1.1

—

Other cataract

318

1969

1.23

3.03

1.3

0.55

0.23

nmol/l

0.63

155

Pregnancy with abortive outcome

527

2344

1.18

3.02

1.2

0.21

0.23

nmol/l

0.15

132

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

10.62

3.02

1.2

1.4

—

nmol/l

—

Abscess of anal and rectal regions

362

1.61

3.01

1.3

0.13

0.31

nmol/l

—

Benign neoplasm: Ascending colon

102

719

1.43

2.99

1.6

1.3

0.26

0.29

nmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

127

929

1.37

2.98

1.2

1.3

0.26

0.27

nmol/l

—

Charcot foot

2.67

2.98

1.4

—

0.58

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

101

711

1.43

2.98

1.4

1.3

0.14

0.34

nmol/l

—

Other pleural conditions

411

1.57

2.95

1.2

1.3

0.34

0.28

nmol/l

—

Other adrenocortical overactivity

4.84

2.94

1.1

1.4

—

Erosion of teeth , including avohilmo

176

1355

1.30

2.93

1.3

0.18

0.25

nmol/l

—

Myeloproliferative diseases

397

1.57

2.91

1.3

1.2

0.18

0.38

nmol/l

—

Other disorders of patella

123

900

1.37

2.90

1.2

1.3

0.16

0.27

nmol/l

—

Enterocolitis due to Clostridium difficile

477

1.52

2.89

1.1

1.3

0.38

0.33

nmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

115

833

1.39

2.89

1.3

0.14

0.28

nmol/l

—

Idiopathic gout

382

1.58

2.88

1.2

1.3

0.21

0.29

nmol/l

—

Parkinson's disease, strict definition, excluding more controls

454

1.52

2.88

1.5

1.3

0.81

0.17

nmol/l

4.32

Suicide or other Intentional self-harm

175

1351

1.30

2.87

1.3

1.2

0.17

0.24

nmol/l

0.73

Reimbursement for rheumatic diseases

437

3700

1.18

2.86

1.2

1.3

0.22

0.23

nmol/l

0.08

234

Other viral diseases, not elsewhere classified

127

934

1.36

2.85

1.2

1.3

0.12

0.28

nmol/l

—

Polyglandular dysfunction, other/unspecified

9.40

2.84

3.2

1.2

—

Seborrhoeic dermatitis

448

1.53

2.82

1.4

1.3

0.16

0.31

nmol/l

—

Other and unspecified local infections of skin and subcutaneous tissue

440

1.53

2.82

1.3

1.2

0.32

0.31

nmol/l

—

Acute laryngitis and tracheitis

504

1.49

2.81

1.2

1.3

0.12

0.27

nmol/l

—

Biological medication for rheuma

125

925

1.36

2.77

1.2

1.3

0.22

0.29

nmol/l

—

Atrophic disorders of skin

116

849

1.37

2.76

1.2

1.3

0.14

0.30

nmol/l

—

Medial epicondylitis

167

1.87

2.73

1.0

1.4

—

0.49

—

Other maltreatment syndromes

132

1.99

2.71

1.3

0.14

0.50

nmol/l

—

Cardiomyopathy (excluding other)

542

1.46

2.70

1.4

1.3

0.19

0.50

nmol/l

0.97

Pre-eclampsia superimposed on chronic hypertension

3.87

2.70

1.1

—

nmol/l

—

Disorders of puberty

3.49

2.70

1.3

1.2

—

nmol/l

—

Acne vulgaris

326

1.60

2.68

1.2

1.3

—

0.44

nmol/l

—

Herpesviral [herpes simplex] infections

568

1.45

2.68

1.5

1.3

0.12

0.35

nmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

280

1.65

2.67

1.4

0.17

0.39

nmol/l

—

Other local infections of skin and subcutaneous tissue

470

1.50

2.67

1.3

1.2

0.29

0.30

nmol/l

—

Bursitis of shoulder

2.15

2.66

1.9

1.2

—

0.54

nmol/l

—

Burns and corrosions confined to eye and internal organs

2.14

2.66

1.2

1.3

—

0.58

—

Medicines for HER+ breast cancer

203

2405

0.80

2.65

1.4

1.3

0.19

0.23

nmol/l

—

152

Other bursopathies

645

1.42

2.63

1.2

1.3

0.29

0.28

nmol/l

—

Nonischemic cardiomyopathy

415

1.52

2.62

1.4

1.3

0.20

0.32

nmol/l

0.52

Psoriasis

205

1635

1.26

2.62

1.3

0.15

0.24

nmol/l

1.91

116

Pediculosis, acariasis and other infestations

111

814

1.37

2.62

1.2

1.3

0.11

0.28

nmol/l

—

Diagnoses used for exclusion with ILD

171

1334

1.29

2.62

1.3

0.23

0.24

nmol/l

—

Non-small cell lung cancer, including Hilmo

615

1.41

2.62

1.1

1.3

0.11

0.35

nmol/l

—

5-aminosalicylic acid

146

1116

1.31

2.61

1.2

1.3

0.28

0.27

nmol/l

—

Delayed puberty

4.74

2.61

1.3

—

nmol/l

—

Malignant neoplasm of digestive organs

253

1626

1.23

2.60

1.4

1.2

0.18

0.27

nmol/l

0.83

123

D07AA Corticosteroids, weak (group I)

104

756

1.38

2.57

1.3

1.2

0.10

0.37

nmol/l

—

Covid-19 suspected case

153

1180

1.30

2.57

1.1

1.3

0.22

0.24

nmol/l

—

Preterm labour and delivery

199

1586

1.26

2.57

1.2

1.3

0.14

0.24

nmol/l

—

Nontoxic diffuse goitre

142

1.92

2.57

1.3

1.2

—

0.64

nmol/l

—

Basal cell carcinoma

299

1713

1.21

2.57

1.3

1.2

0.18

0.27

nmol/l

0.84

129

Wet age-related macular degeneration

105

743

1.38

2.56

1.2

1.3

0.14

0.26

nmol/l

—

Rheumatoid arthritis

222

1605

1.24

2.56

1.2

1.3

0.18

0.28

nmol/l

1.01

116

Suppurative and unspecified otitis media

242

1745

1.23

2.55

1.4

1.3

0.15

0.24

nmol/l

0.94

Infective dermatitis

566

1.44

2.54

1.4

1.3

0.24

0.34

nmol/l

—

Malignant neoplasm of pancreas

261

1.66

2.54

1.8

1.3

0.16

0.43

nmol/l

—

Open wound of head

372

3042

1.18

2.54

1.2

1.3

0.25

0.23

nmol/l

0.09

210

Crohn's disease of small intestine

308

1.60

2.53

1.3

0.19

0.35

nmol/l

—

Crohn disease (strict definition, require KELA)

285

1.62

2.52

1.4

1.3

0.17

0.39

nmol/l

—

Hypertrophy of breast in women and men

147

1134

1.30

2.48

1.3

0.26

nmol/l

—

Tonsillectomy and adenotomy

405

2406

1.17

2.47

1.3

0.17

0.21

nmol/l

0.53

109

Recurrent aphthous stomatitis , including avohilmo

100

729

1.38

2.47

1.3

0.12

0.30

nmol/l

—

Macular pucker

106

782

1.36

2.44

1.3

0.16

0.30

nmol/l

—

Patellar tendinitis

3.15

2.44

1.2

1.5

—

0.58

nmol/l

—

Hallux valgus (acquired)

242

1420

1.23

2.43

1.2

1.3

0.19

0.26

nmol/l

0.75

Malignant neoplasm of prostate

147

674

1.31

2.42

1.4

1.3

0.14

0.24

nmol/l

0.76

Postprocedural musculoskeletal disorders, not elsewhere classified

336

1.56

2.41

1.3

0.54

0.40

nmol/l

—

Bell's palsy

556

1.43

2.41

1.3

0.12

0.31

nmol/l

—

Other noninflammatory disorders of vagina

384

1.52

2.40

1.3

1.2

—

0.31

nmol/l

—

Other infectious diseases

336

1.56

2.40

1.3

0.12

0.35

nmol/l

—

Lung cancer and mesothelioma

117

750

1.34

2.40

1.2

1.3

0.14

0.28

nmol/l

—

Myocardial infarction, with ST-elevation

716

1.37

2.40

1.3

0.24

0.26

nmol/l

0.10

Hereditary hypogammaglobulinemia

4.29

2.39

1.3

1.1

—

Peripheral artery operations in Hilmo

482

1.46

2.38

1.3

0.14

0.26

nmol/l

0.86

Injury of muscle and tendon at shoulder and upper arm level

247

2035

1.22

2.37

1.2

1.3

0.18

0.29

nmol/l

1.27

154

Presence of other devices

144

1112

1.29

2.35

1.2

1.3

0.29

0.33

nmol/l

0.10

Stomatitis and related lesions

139

1074

1.30

2.34

1.3

0.17

0.26

nmol/l

—

Chondropathies

105

780

1.35

2.33

1.3

0.30

0.29

nmol/l

—

Sequelae of other external causes

237

1.66

2.32

1.4

1.3

0.14

0.30

nmol/l

—

Impacted cerumen

453

1.46

2.31

1.3

0.16

0.36

nmol/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

4.78

2.30

2.7

1.5

—

malignant neoplasm of male genital organs

152

720

1.29

2.28

1.4

1.3

0.15

0.24

nmol/l

0.69

Pleural effusion

681

1.37

2.27

1.3

0.11

0.30

nmol/l

—

L02BG Aromatase inhibitors

165

2062

0.80

2.25

1.3

0.17

0.24

nmol/l

—

142

Flat foot [pes planus] (acquired)

514

1.43

2.24

1.3

0.15

0.39

nmol/l

—

Other infectious diseases

399

1.49

2.23

1.3

0.12

0.40

nmol/l

—

Malignant melanoma of skin, including Hilmo

658

1.37

2.22

1.2

1.3

0.23

0.38

nmol/l

0.80

Other other unspecified disorders of the circulatory system

157

1.80

2.22

1.3

1.2

—

0.43

nmol/l

—

IBD patients in KELA-register

155

1224

1.27

2.22

1.3

0.22

0.25

nmol/l

0.15

Congenital malformations of genital organs

430

1.46

2.21

1.3

—

0.56

nmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

161

1278

1.26

2.21

1.2

1.3

0.16

0.22

nmol/l

—

Redundant prepuce, phimosis and paraphimosis

119

899

1.31

2.21

1.2

1.3

0.13

0.31

nmol/l

—

Malignant melanoma of skin

492

1.43

2.18

1.2

1.3

0.23

0.32

nmol/l

—

Defect, injury or illness of neck

4.38

2.16

1.5

1.3

—

Isolated growth hormone deficiency

4.36

2.16

1.0

1.3

—

Flatulence and related conditions

3.04

2.16

1.7

1.1

—

Puerperal sepsis

105

791

1.33

2.16

1.3

0.14

0.32

nmol/l

1.86

Assault by bodily force

354

1.50

2.14

1.1

1.3

0.33

0.30

nmol/l

—

Acute suppurative otitis media

168

1255

1.25

2.13

1.4

1.3

0.17

0.27

nmol/l

—

Schizophrenia or delusion, excluding more controls

188

1510

1.24

2.13

1.3

0.24

0.26

nmol/l

0.13

Asthma and opportunity respiratory infection

182

1.72

2.12

1.5

1.3

—

0.48

—

Tetraplegia

3.27

2.11

1.3

1.2

—

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

306

1778

1.18

2.10

1.3

1.2

0.20

0.26

nmol/l

0.50

133

Melanocytic naevi

206

1692

1.22

2.09

1.4

1.3

0.24

nmol/l

0.01

105

Fluid overload

5.17

2.09

1.2

1.1

—

nmol/l

—

Superficial injury of thorax

726

1.34

2.09

1.3

0.24

0.25

nmol/l

—

Pedal cyclist injured in transport accident

153

1217

1.26

2.08

1.2

1.3

0.13

0.25

nmol/l

—

Malignant neoplasm of prostate, including Hilmo

149

696

1.27

2.08

1.4

1.3

0.14

0.24

nmol/l

0.75

Mild or no visual impairment, binocular

4.10

2.05

1.0

1.3

—

Alcohol abuse, main dg, excluding more controls

642

1.36

2.05

1.2

1.3

0.16

0.27

nmol/l

—

Viral warts

145

1149

1.27

2.05

1.2

1.3

0.12

0.28

nmol/l

—

Subacute thyroiditis

169

1.73

2.05

1.2

—

0.41

nmol/l

—

Glaucoma suspect

255

2145

1.19

2.02

1.2

1.3

0.16

0.24

nmol/l

1.22

166

Epiphora

2.02

2.01

1.2

1.3

—

0.74

nmol/l

—

Gastrojejunal ulcer

2.67

2.01

1.0

1.4

—

0.16

—

Spermatocele

255

1.58

2.00

1.3

—

0.26

nmol/l

—

Pyogenic arthritis

271

1.56

2.00

1.7

1.3

0.18

0.41

nmol/l

—

Use of rivastigmine

634

0.66

1.99

1.3

0.40

0.27

nmol/l

—

Acromegaly and pituitary gigantism

3.40

1.98

1.0

1.2

—

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

731

4223

1.11

1.98

1.2

1.3

0.23

0.24

nmol/l

0.06

268

Labour and delivery complicated by fetal stress [distress]

815

0.75

1.97

1.3

—

0.21

nmol/l

—

Other hypertrichosis

4.68

1.96

1.2

1.3

—

Second line medication for Crohn's disease

427

3749

1.14

1.94

1.2

1.3

0.24

0.23

nmol/l

0.08

236

Alcohol dependence

168

1364

1.23

1.93

1.2

1.3

0.17

0.28

nmol/l

1.50

Benign neoplasm: Rectosigmoid junction

165

1.71

1.91

1.1

1.2

—

0.46

—

Congenital malformations and deformations of the musculoskeletal system

494

1.39

1.91

1.3

0.14

0.40

nmol/l

—

Synovial cyst of popliteal space [Baker]

331

1.49

1.91

1.3

0.31

0.46

nmol/l

—

Female infertility

197

982

1.22

1.90

1.2

1.3

0.20

nmol/l

—

Other diseases of biliary tract

406

1.44

1.89

1.3

0.14

0.37

nmol/l

—

Crohn disease (strict definition, all UC cases excluded)

212

1.61

1.89

1.4

1.3

0.16

0.37

nmol/l

—

Open wound of thorax

2.33

1.88

1.2

1.6

—

0.58

—

Retinal detachments and breaks

238

2005

1.19

1.88

1.3

0.26

0.28

nmol/l

0.11

161

Deficiency of other B group vitamins

2.05

1.86

1.1

1.2

—

0.12

nmol/l

—

Benign neoplasm: Retina

3.60

1.85

3.3

1.3

—

nmol/l

—

Other and unspecified cicatricial alopecia

4.33

1.84

1.4

1.2

—

nmol/l

—

Kela-code for severe mental illness

252

2139

1.18

1.84

1.2

1.3

0.18

0.23

nmol/l

0.98

119

Nonsuppurative otitis media

143

993

1.25

1.82

1.4

1.3

0.18

0.33

nmol/l

0.90

Benign neoplasm of ovary

135

1080

1.25

1.81

1.3

0.48

0.27

nmol/l

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

311

1.49

1.80

1.4

1.3

0.17

0.37

nmol/l

—

Effects of foreign body entering through natural orifice

154

1250

1.24

1.80

1.3

0.34

0.21

nmol/l

0.28

Tumor necrosis factor alpha inhibitors

107

832

1.29

1.80

1.2

1.3

0.24

0.30

nmol/l

—

All dysplastic lesions of the vulva

215

1.59

1.80

1.1

1.3

—

0.38

nmol/l

—

Acute appendicitis, with complications

128

1018

1.26

1.80

1.1

1.3

0.23

0.25

nmol/l

—

Osteonecrosis

279

1.51

1.79

1.5

1.3

0.36

0.45

nmol/l

—

Dermatophytosis

633

1.33

1.78

1.4

1.3

0.32

0.30

nmol/l

—

Hypertrophy of breast

129

1029

1.26

1.77

1.2

0.14

0.25

nmol/l

—

Sequelae of injuries of upper limb

488

1.38

1.77

1.5

1.3

0.15

0.34

nmol/l

—

Acute lymphadenitis

248

1.54

1.76

1.2

1.3

0.12

0.45

nmol/l

—

Other and unspecified disorders of binocular movement

3.40

1.76

1.3

1.1

—

nmol/l

—

Cicatricial alopecia [scarring hair loss]

2.55

1.75

1.3

—

nmol/l

—

Seborrhoeic keratosis

155

1264

1.23

1.75

1.3

0.19

0.27

nmol/l

0.74

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.25

1.75

1.0

1.5

—

0.58

—

Other hammer toe(s) (acquired)

124

909

1.26

1.75

1.3

0.22

0.29

nmol/l

0.52

L04AX Other immunosuppressants

413

3651

1.13

1.73

1.2

1.3

0.25

0.23

nmol/l

0.11

230

Benign neoplasm: Pelvic bones, sacrum and coccyx

3.93

1.73

1.2

—

Male infertility

186

1.62

1.72

1.4

—

0.33

nmol/l

—

Inflammatory bowel disease, strict (require KELA)

155

1268

1.23

1.70

1.3

0.22

0.24

nmol/l

0.14

Event of undetermined intent

267

1.51

1.68

1.3

0.10

0.28

nmol/l

—

Lymphoid leukaemia

211

1.57

1.68

1.6

1.3

0.15

0.39

nmol/l

—

Other specified/unspecified deforming dorsopathies

2.20

1.68

1.1

1.4

—

0.58

nmol/l

—

Other disorders of peripheral nervous system

3.21

1.67

1.3

1.2

—

Recurrent and persistent haematuria

2.62

1.67

1.0

1.2

—

nmol/l

—

Disorders of parathyroid gland, other and/or unspecified

2.85

1.66

2.0

1.2

—

nmol/l

—

Other conjunctival vascular disorders and cysts

1.91

1.66

1.2

—

0.50

nmol/l

—

Purpura and other haemorrhagic conditions

650

1.31

1.65

1.4

1.3

0.31

0.33

nmol/l

—

Other respiratory diseases principally affecting the interstitium

105

826

1.27

1.64

1.4

1.3

0.14

0.29

nmol/l

1.97

Fracture at wrist and hand level

233

1983

1.17

1.64

1.2

1.3

0.13

0.25

nmol/l

2.82

126

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.42

1.63

1.1

1.5

—

0.48

—

Seronegative rheumatoid arthritis

621

1.31

1.56

1.2

1.3

0.12

0.31

nmol/l

—

Dermatophytosis

431

3848

1.12

1.55

1.4

1.3

0.26

0.23

nmol/l

0.11

253

Macular cyst

122

1.74

1.55

1.1

1.3

—

0.53

—

Ectopic pregnancy

124

1003

1.24

1.55

1.3

1.2

0.18

0.23

nmol/l

—

Other or unspecified common variable immunodeficiency

3.43

1.54

1.2

1.3

—

Coxarthrosis, primary

417

3148

1.12

1.54

1.3

0.18

0.25

nmol/l

0.97

247

Use of disulfiram, acamprosate or naltrexone

407

1.38

1.53

1.1

1.3

0.14

0.21

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

265

1.48

1.53

1.3

—

0.41

nmol/l

—

Other congenital malformations of tongue, mouth and pharynx

0.00

1.53

0.0

1.2

—

Benign neoplasm: Ill-defined sites within the digestive system

2.64

1.53

2.3

1.1

—

nmol/l

—

Unspecified abortion

258

0.54

1.52

1.1

1.3

—

0.32

nmol/l

—

Ascites

299

1.44

1.51

1.5

1.3

0.18

0.31

nmol/l

—

Alcohol withdrawal state with delirium

283

1.46

1.50

1.4

1.3

0.14

0.25

nmol/l

—

Other disorders of veins

295

2568

1.14

1.49

1.3

0.20

nmol/l

0.03

164

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

421

2979

1.12

1.49

1.3

0.17

0.24

nmol/l

1.04

171

Fall on and from stairs and steps

172

1445

1.19

1.48

1.3

0.18

0.23

nmol/l

0.65

Other and unspecified disorders of psychological development

2.56

1.48

1.1

—

Maternal care for other conditions predominantly related to pregnancy

132

1060

1.22

1.48

1.2

0.20

0.21

nmol/l

—

Myopia

609

1.30

1.48

1.3

0.14

0.32

nmol/l

—

severe traumatic brain injury, does not include concussion

129

1056

1.22

1.46

1.1

1.3

0.16

0.25

nmol/l

—

Thyrotoxicosis factitia

3.22

1.45

1.2

1.3

—

Other and unspecified myoneural disorders

3.20

1.45

1.4

1.2

—

nmol/l

—

ILD, hospital admission 2, with pulmonary infections

386

1.38

1.45

1.5

1.3

0.15

0.37

nmol/l

—

Primary amenorrhea

3.16

1.44

1.4

1.3

—

Other maternal disorders predominantly related to pregnancy

424

2379

1.12

1.43

1.2

1.3

0.14

0.24

nmol/l

2.04

123

Fracture of forearm

407

3339

1.12

1.43

1.3

0.18

0.21

nmol/l

0.63

203

Disorder of external ear, unspecified

141

1.64

1.42

1.1

1.3

—

0.45

—

Diabetic retinopathy, excluding more controls

209

999

1.18

1.41

1.3

1.4

0.22

0.25

nmol/l

0.17

Psoriasis vulgaris

121

989

1.23

1.40

1.3

0.13

0.26

nmol/l

—

Superficial injury of hip and thigh

676

1.27

1.39

1.3

0.24

0.32

nmol/l

—

Sulfasalazine

192

1639

1.17

1.39

1.2

1.3

0.26

0.25

nmol/l

—

105

Multiple delivery

469

0.68

1.38

1.2

1.3

0.12

0.20

nmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

127

1.66

1.37

1.3

1.4

—

0.58

nmol/l

—

Other surgical follow-up care

135

1.64

1.36

1.1

1.3

—

0.49

nmol/l

—

LSIL lesion of the vulva

143

1.62

1.36

1.1

1.3

—

0.50

nmol/l

—

Complications associated with artificial fertilization

2.14

1.34

2.3

1.1

—

nmol/l

—

Family history of other conditions

2.06

1.33

2.3

1.2

—

Mucosal proctocolitis

620

1.28

1.32

1.2

1.3

0.28

0.32

nmol/l

—

Other congenital malformations of limb(s)

2.53

1.31

3.7

1.3

—

Colorectal cancer

133

1083

1.20

1.30

1.3

1.2

0.23

0.31

nmol/l

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

446

1.32

1.28

1.4

1.3

0.18

0.34

nmol/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

155

1249

1.18

1.27

1.2

0.15

0.26

nmol/l

1.62

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

302

1.40

1.27

1.3

0.13

0.39

nmol/l

—

Lung diseases due to external agents

589

1.28

1.26

1.4

1.3

0.18

0.30

nmol/l

—

Other and unspecified vaccines and biological substances

2.43

1.25

1.0

1.2

—

Nasal polyp

116

959

1.21

1.24

1.3

0.13

0.22

nmol/l

—

Dilated cardiomyopathy

503

1.30

1.23

1.4

1.3

0.20

0.27

nmol/l

0.38

Disorders of myoneural junction and muscle in diseases classified elsewhere

2.19

1.22

3.4

1.3

—

nmol/l

—

Burns and corrosions

663

1.26

1.22

1.2

1.3

0.13

0.26

nmol/l

—

Lichen planus, including avohilmo

131

1098

1.20

1.22

1.3

0.21

0.27

nmol/l

—

Other degenerative diseases of the nervous system

154

975

1.18

1.21

1.3

0.16

0.18

nmol/l

0.17

Rheumatic fever incl heart disease

109

1.66

1.19

1.3

1.2

—

0.70

nmol/l

—

Primary open-angle glaucoma

199

1672

1.15

1.18

1.3

0.18

0.27

nmol/l

0.74

129

Fracture of shoulder and upper arm

239

2104

1.14

1.17

1.4

1.3

0.16

0.23

nmol/l

1.49

137

Other keratitis

543

1.27

1.16

1.2

1.3

0.15

0.28

nmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

129

0.46

1.16

1.2

—

0.46

nmol/l

—

Microscopic polyangiitis

0.00

1.16

0.0

1.2

—

Valvular operations

570

1.27

1.15

1.6

1.3

0.14

0.45

nmol/l

—

Viral conjunctivitis

158

1.53

1.15

1.2

1.3

—

0.70

nmol/l

—

Disorders of synovium and tendon in diseases classified elsewhere

1.76

1.13

1.1

1.3

—

0.64

—

Benign neoplasm: Skin of other and unspecified parts of face

510

1.28

1.13

1.3

0.12

0.36

nmol/l

—

Unspecified misadventure during surgical and medical care

250

1.41

1.13

1.7

1.3

0.23

0.41

nmol/l

—

Other congenital malformations of face and neck

111

1.63

1.12

1.2

1.3

—

0.44

nmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

126

1062

1.19

1.12

1.2

1.3

0.13

0.30

nmol/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

717

1.23

1.11

1.2

1.3

0.14

0.31

nmol/l

—

Benign mammary dysplasia

102

845

1.21

1.10

1.3

0.14

0.30

nmol/l

—

Androgenic alopecia

1.97

1.09

1.1

1.2

—

nmol/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

143

1222

1.17

1.09

1.3

0.17

0.27

nmol/l

1.22

Inguinal hernia, bilateral

410

0.71

1.08

1.4

1.3

0.60

0.21

nmol/l

—

Cutis laxa senilis

2.15

1.06

1.0

1.2

—

Organic, including symptomatic, mental disorders

274

2178

0.89

1.06

1.3

0.31

0.26

nmol/l

0.22

173

Premenstrual syndrome

2.14

1.06

1.1

1.2

—

Benign neoplasm: Skin of upper limb, including shoulder

1.72

1.05

1.6

1.3

—

0.82

nmol/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

245

1.39

1.05

1.1

1.2

—

0.36

nmol/l

—

Use of galantamine

277

0.65

1.04

1.7

1.3

—

0.31

nmol/l

—

Unspecified lump in breast

111

933

1.19

1.04

1.3

0.36

0.29

nmol/l

—

Vaginal lichen planus

2.31

1.04

1.2

1.3

—

Spontaneous abortion

329

2004

1.11

1.03

1.3

1.2

0.27

0.24

nmol/l

0.12

107

Primary open-angle glaucoma, strict

163

1412

1.15

1.03

1.3

0.20

0.28

nmol/l

0.57

113

Recurrent dislocation of patella

196

1.43

1.02

1.1

1.3

—

0.56

nmol/l

—

Inguinal or femoral hernia, bilateral

416

0.72

1.02

1.4

1.3

0.60

0.21

nmol/l

—

Other ulcerative colitis

256

1.37

1.00

1.1

1.3

—

0.34

nmol/l

—

Pterygium

1.63

1.00

1.3

—

0.46

nmol/l

—

Varicose veins

436

3023

1.09

1.00

1.2

1.3

0.27

0.24

nmol/l

0.16

206

Corns and callosities

317

1.33

0.99

1.2

1.3

—

0.45

—

Implicit parasitic Sepsis

2.20

0.98

1.6

1.3

—

nmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

106

893

1.19

0.98

1.2

1.3

0.13

0.31

nmol/l

—

Single delivery by forceps and vacuum extractor

468

0.80

0.98

1.2

1.3

—

0.18

nmol/l

—

Inguinal hernia

379

2314

1.10

0.97

1.4

1.3

0.40

0.26

nmol/l

0.44

167

Other demyelinating diseases of the central nervous system

157

1.47

0.96

1.5

1.3

—

0.53

nmol/l

—

Other bursitis of hip

1.70

0.95

1.1

1.3

—

0.59

—

Alcoholic liver disease

434

1.27

0.95

1.5

1.3

0.14

0.27

nmol/l

1.13

Ulcerative colitis (strict definition, require KELA)

103

869

1.19

0.95

1.2

1.3

0.28

nmol/l

—

Amputation

390

1.28

0.94

1.2

1.3

0.12

0.29

nmol/l

—

Endometriosis of fallopian tube

2.25

0.94

1.2

—

Abscess of lung

1.74

0.92

1.4

—

0.58

nmol/l

—

Other and unspecified nonscarring hair loss

2.17

0.92

1.3

—

Urticaria due to cold and heat

2.16

0.92

1.0

1.1

—

Other congenital malformations of female genitalia

2.16

0.92

1.2

—

Chorioretinal inflammation

118

1.53

0.91

1.1

1.3

—

0.52

nmol/l

—

Drug-induced systemic lupus erythematosus

2.10

0.90

1.3

1.2

—

Status post-ami

131

862

1.16

0.89

1.3

0.26

0.34

nmol/l

—

Embolic stroke with flimmer

1.70

0.89

1.2

1.3

—

0.12

nmol/l

—

Other interstitial pulmonary diseases

704

1.20

0.86

1.5

1.3

0.15

0.30

nmol/l

—

Carcinoma in situ of vulva

1.95

0.85

1.2

—

Interstitial lung disease

706

1.19

0.84

1.5

1.3

0.15

0.30

nmol/l

—

Interstitial lung disease endpoints

706

1.19

0.84

1.5

1.3

0.15

0.30

nmol/l

—

Malignant neoplasm of breast, HER-negative

135

1157

1.15

0.83

1.2

0.15

0.27

nmol/l

1.71

Pregnancy, childbirth and the puerperium

196

911

1.13

0.83

1.2

1.3

0.41

0.26

nmol/l

—

Embolic stroke

154

1.43

0.83

1.4

1.3

—

0.43

nmol/l

—

ILD, hospital admissions

700

1.19

0.80

1.5

1.3

0.15

0.30

nmol/l

—

Dermatopolymyositis (FG)

1.74

0.80

1.0

1.3

—

0.87

nmol/l

—

Drug-induced obesity

1.83

0.79

1.2

—

Diabetic neuropathy

634

1.20

0.79

1.2

1.4

0.10

0.17

nmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

1.68

0.79

1.2

1.3

—

0.58

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

321

1.28

0.79

1.0

1.3

—

0.37

nmol/l

—

Uterine polyps

510

1.22

0.78

1.1

1.2

—

0.25

nmol/l

—

Melanocytic naevi of lower limb, including hip

199

1.36

0.78

1.4

1.3

0.24

0.45

nmol/l

—

Keratoconus

0.51

0.78

1.0

1.4

—

0.50

nmol/l

—

Malignant neoplasm of bronchus and lung, including Hilmo

115

835

1.15

0.78

1.2

0.14

0.31

nmol/l

—

Palmar fascial fibromatosis [Dupuytren]

648

1.19

0.77

1.2

1.3

0.17

0.33

nmol/l

—

Malignant neoplasm of rectosigmoid junction

1.65

0.75

1.0

1.3

—

0.52

nmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

110

794

1.15

0.75

1.2

0.14

0.32

nmol/l

—

Open wound of wrist and hand

282

2529

1.09

0.75

1.3

0.24

0.27

nmol/l

—

164

Seropositive rheumatoid arthritis

159

1412

1.12

0.74

1.2

1.3

0.22

0.27

nmol/l

—

113

Maternal care for known or suspected fetal abnormality and damage

666

0.84

0.71

1.6

1.2

—

0.20

nmol/l

—

Unspecified parasitic disease

1.94

0.71

1.0

1.2

—

Follicular lymphoma, hilmo

177

1.36

0.71

1.1

1.3

—

0.44

nmol/l

—

Use of levodopa decarboxylase inhibitor

618

1.18

0.70

1.5

1.3

0.81

0.22

nmol/l

3.73

Alzheimer’s disease (Late onset), excluding more controls

401

0.82

0.70

1.4

1.3

0.12

0.14

nmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

109

953

1.15

0.70

1.2

1.3

0.28

0.27

nmol/l

—

Retinal detachment with retinal break

628

1.18

0.70

1.5

1.3

0.18

0.27

nmol/l

—

Left hemicolectomy

1.54

0.69

1.6

1.3

—

0.70

—

Reactive arthropathies, FINNGEN

319

1.26

0.69

1.2

1.3

—

0.44

nmol/l

—

Malignant neoplasm of renal pelvis, including Hilmo

1.68

0.68

1.1

1.4

—

0.14

nmol/l

—

Parkinson's disease, including avohilmo

722

1.17

0.68

1.4

1.3

0.73

0.20

nmol/l

3.66

Chronic ulcer of skin, not elsewhere classified

302

1.26

0.67

1.4

1.3

0.14

0.39

nmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

148

1325

1.12

0.67

1.3

0.21

0.27

nmol/l

—

Alcohol abuse, main dg

752

1.16

0.66

1.2

1.3

0.16

0.26

nmol/l

—

Other corneal oedema

1.80

0.66

1.2

1.3

—

Contraceptive management

239

1827

0.92

0.66

1.2

1.3

0.16

0.23

nmol/l

0.48

119

Other specific arthropathies, wide

1.52

0.66

1.2

1.3

—

0.74

nmol/l

—

Use of selegiline

162

1.36

0.66

1.5

1.3

0.98

0.36

nmol/l

1.89

Convergent concomitant strabismus

250

1.28

0.65

1.5

1.3

—

0.42

nmol/l

—

Injury of muscle and tendon at lower leg level

744

1.16

0.65

1.2

1.3

0.10

0.26

nmol/l

—

Other diseases of appendix

1.60

0.65

1.0

1.2

—

ILD, hospital admissions 3, with pneumonia sepsis

349

1.23

0.65

1.5

1.3

0.13

0.40

nmol/l

—

Acute alcohol intoxication

142

1272

1.12

0.64

1.2

1.3

0.17

0.28

nmol/l

1.05

Other vitreous opacities

163

1.35

0.64

1.1

1.3

—

0.28

nmol/l

—

Accessory breast

1.74

0.64

1.8

1.2

—

Struck by thrown, projected or falling objec

198

1.32

0.64

1.1

1.3

—

0.30

nmol/l

—

Retinal breaks without detachment

914

0.86

0.64

1.4

1.3

0.44

0.23

nmol/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

112

1.43

0.63

1.1

1.2

—

0.58

nmol/l

—

Other (seronegative) rheumatoid arthritis, wide

117

1037

1.13

0.63

1.2

1.3

0.18

0.26

nmol/l

0.67

Open wound of abdomen, lower back and pelvis

112

1.43

0.63

1.3

1.4

—

0.44

nmol/l

—

Primary coxarthrosis, bilateral

179

1627

1.10

0.62

1.3

0.21

0.27

nmol/l

0.47

126

Personal history of allergy to drugs, medicaments and biological substances

1.61

0.61

1.1

1.2

—

Burn and corrosion, body region unspecified

0.00

0.60

0.0

1.3

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.60

0.0

1.1

—

Parkinson's disease

694

1.15

0.60

1.5

1.3

0.73

0.20

nmol/l

3.68

Malignant neoplasm of breast, ER-positive, including Hilmo

193

1627

0.91

0.60

1.4

1.2

0.19

0.27

nmol/l

—

1.51

0.60

1.2

1.3

—

0.68

—

Gestational diabetes (for exclusion)

219

1399

1.09

0.59

1.2

1.3

0.18

0.19

nmol/l

—

Use of entacapone

0.00

0.59

0.0

1.2

—

Hereditary corneal dystrophies

150

0.66

0.58

1.1

1.2

—

0.60

nmol/l

—

Maternal care for other known or suspected fetal problems

135

767

1.12

0.58

1.2

1.3

—

0.19

nmol/l

—

Respiratory disorders in diseases classified elsewhere

1.49

0.57

1.4

1.1

—

Malignant neoplasm of bronchus and lung

679

1.14

0.57

1.2

0.14

0.34

nmol/l

—

Congenital obstruction of the pelviureteric junction

1.68

0.57

1.3

1.2

—

nmol/l

—

Cytomegaloviral disease

1.45

0.55

1.4

1.3

—

0.66

nmol/l

—

Persons encountering health services in circumstances related to reproduction

401

2545

1.06

0.55

1.6

1.3

0.17

0.22

nmol/l

0.69

160

Mixed disorders of conduct and emotions, excluding more controls

1.54

0.55

1.0

1.1

—

Other/unspecified reactive arthropathies

284

1.24

0.55

1.1

1.3

—

0.37

nmol/l

—

All dysplastic lesions of the vagina

133

1.36

0.55

1.1

1.3

—

0.43

—

Acute alcohol intoxication, ICD10

113

1012

1.12

0.54

1.2

1.3

0.18

0.25

nmol/l

—

Systemic sclerosis,strict definition

1.59

0.54

1.5

1.2

—

Unspecified acute lower respiratory infection

692

1.14

0.54

1.4

1.3

0.19

0.27

nmol/l

—

Malignant neoplasm of breast, HER-positive

191

1615

0.92

0.52

1.4

1.2

0.19

0.25

nmol/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

1.44

0.52

1.2

1.5

—

0.47

—

Other nonscarring hair loss

1.51

0.52

1.3

1.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

135

1.34

0.51

1.1

1.4

0.12

0.48

nmol/l

—

Other spirochaetal diseases

203

1879

1.08

0.51

1.3

0.12

0.25

nmol/l

—

134

Periodontal disease, other/unspecified

109

1.38

0.51

1.1

1.3

—

0.40

—

Outcome of delivery

509

0.87

0.51

1.3

—

0.16

nmol/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.39

0.50

1.3

—

0.68

nmol/l

—

Erythema multiforme

1.42

0.50

1.2

1.4

—

0.60

—

Ovarian hyperstimulation (induction)

1.50

0.50

2.3

1.2

—

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.50

0.50

1.5

1.3

—

0.70

—

Postpartum care and examination

422

1.14

0.49

1.2

1.3

—

0.19

nmol/l

—

Cytomegalovirus infection, IBD co-morbidity

1.43

0.49

1.4

1.1

—

0.44

nmol/l

—

Acute and transient psychotic disorders

604

1.14

0.49

1.2

1.3

0.16

0.29

nmol/l

—

Complications of labour and delivery

419

2456

0.95

0.49

1.2

1.3

0.16

0.24

nmol/l

1.28

134

Bicuspidal aortic valve syndrome

145

1.31

0.49

1.1

1.4

—

0.35

nmol/l

—

Postpartum haemorrhage due to anatomy

443

0.83

0.48

1.7

1.2

—

0.13

nmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

530

1.15

0.48

1.2

1.3

0.16

0.30

nmol/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

172

1.28

0.48

1.3

1.2

—

0.47

nmol/l

—

Open bite

208

1.25

0.48

1.9

1.3

—

0.44

nmol/l

—

Migraine without aura, drug-induced

1.50

0.47

1.6

1.2

—

Type 1 diabetes, strict definition, subgroup 1

299

1.20

0.47

1.1

1.2

—

0.50

nmol/l

—

Coxarthrosis, primary, with hip surgery

302

2664

1.06

0.46

1.3

0.20

0.26

nmol/l

0.67

205

Parkinson's disease, strict definition

637

1.13

0.45

1.5

1.3

0.81

0.21

nmol/l

3.84

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

292

1.20

0.45

1.2

1.3

—

0.40

nmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

713

1.12

0.45

1.4

1.3

0.15

0.26

nmol/l

1.24

Injuries to the hip and thigh

295

2520

1.06

0.45

1.3

0.18

0.27

nmol/l

0.94

176

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

157

1.28

0.43

1.2

1.3

—

0.46

nmol/l

—

1.62

0.43

1.0

1.1

—

ILD, hospital admissions 1, main diag only

631

1.13

0.42

1.5

1.3

0.14

0.30

nmol/l

—

Crossbite

255

1.20

0.42

1.1

1.3

—

0.39

nmol/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.55

0.42

1.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

272

1.20

0.41

1.3

—

0.51

nmol/l

—

Caries of enamel

648

4503

1.04

0.41

1.3

0.16

0.25

nmol/l

1.91

268

Other and unspecified localized connective tissue disorders

0.00

0.41

0.0

1.3

—

Erysipeloid

0.00

0.41

0.0

1.3

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.41

0.0

1.3

—

Other spirochaetal diseases

197

1842

1.07

0.41

1.2

1.3

0.12

0.23

nmol/l

—

131

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.41

0.0

1.3

—

Use of riluzole

0.00

0.41

0.0

1.2

—

Thalassaemia

0.00

0.41

0.0

1.2

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.41

0.0

1.2

—

Adenocarcinomas of cervix

0.00

0.41

0.0

1.3

—

Desensitization to allergens

213

1.22

0.40

1.2

1.3

—

0.44

nmol/l

—

Malignant neoplasm of rectum, including Hilmo

539

1.13

0.40

1.1

1.3

0.10

0.39

nmol/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

160

0.75

0.39

1.4

1.3

—

0.46

—

Alzheimer’s disease (undefined)

0.00

0.39

0.0

1.2

—

Hypoplasia of dental enamel

0.00

0.39

0.0

1.2

—

Molar incisor enamel hypoplasia, with caries

0.00

0.39

0.0

1.2

—

Open wound of lower leg

750

1.11

0.39

1.3

0.22

0.29

nmol/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

169

1.25

0.38

1.3

1.4

—

0.37

nmol/l

—

Benign neoplasm of major salivary glands

485

1.14

0.38

1.2

1.3

0.10

0.36

nmol/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

1.39

0.38

1.0

1.1

—

Burns and corrosions of external body surface, specified by site

514

1.13

0.38

1.2

1.3

0.13

0.29

nmol/l

—

Benign neoplasm: Skin of trunk

179

1.23

0.37

1.4

1.3

—

0.47

nmol/l

—

Coronary artery bypass grafting

119

816

1.09

0.37

1.3

0.13

0.35

nmol/l

1.77

Diabetic maculopathy

762

0.90

0.37

1.3

0.22

0.16

nmol/l

—

Rheumatic valve diseases

1.29

0.36

1.2

1.3

—

0.82

—

Foreign body in genitourinary tract

1.47

0.36

1.0

1.1

—

Divergent concomitant strabismus

342

0.85

0.35

1.1

1.3

—

0.38

nmol/l

—

Malignant neoplasm of cervix uteri, including Hilmo

122

0.74

0.35

1.1

1.2

—

0.40

nmol/l

—

Benign neoplasm: Conjunctiva

135

1.26

0.35

1.0

1.3

—

0.63

nmol/l

—

Delivery, wide proxy

225

1128

1.06

0.35

1.2

1.3

0.31

0.23

nmol/l

0.24

Optic neuritis

181

1.22

0.34

1.1

1.3

—

0.47

nmol/l

—

Short stature, not elsewhere classified

1.36

0.34

1.2

—

nmol/l

—

Type 1 diabetes, strict definition

320

1.15

0.33

1.1

1.2

—

0.50

nmol/l

—

Abrasion of teeth

224

2124

1.06

0.33

1.3

0.13

0.22

nmol/l

—

140

Malignant neoplasm of other and unspecified female genital organs

0.67

0.33

1.0

1.2

—

0.52

nmol/l

—

Delivery

283

1422

1.05

0.33

1.2

1.3

0.38

0.21

nmol/l

0.58

Monoarthritis, not elsewhere classified

173

1.22

0.33

1.2

1.4

—

0.51

nmol/l

—

Spirochaetal infections, other/unspecified

195

1846

1.06

0.31

1.3

0.13

0.23

nmol/l

—

131

Squamous cell neoplasms and carcinomas of the skin

276

1.16

0.31

1.6

1.3

0.20

0.38

nmol/l

—

Mixed disorders of conduct and emotions

1.34

0.30

1.0

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

271

1664

0.95

0.30

1.2

1.3

0.26

0.25

nmol/l

0.05

Oral lichen planus

130

0.77

0.29

1.1

1.3

—

0.61

nmol/l

—

Other disorders of breast and lactation associated with childbirth

1.25

0.29

1.0

1.1

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

213

1.18

0.29

1.1

1.3

—

0.41

nmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

298

1850

1.04

0.28

1.3

1.2

0.17

0.26

nmol/l

1.39

105

Malignant neoplasm of breast, including Hilmo

298

1850

1.04

0.28

1.3

1.2

0.17

0.26

nmol/l

1.39

105

Otosclerosis

383

1.12

0.28

1.5

1.3

0.47

0.40

nmol/l

—

Malignant neoplasm of breast, HER2-negative

288

1806

1.04

0.28

1.3

1.2

0.17

0.26

nmol/l

1.43

103

Rare circulating lymphoid malignancy, including Hilmo

103

1.26

0.28

1.6

1.2

—

0.61

nmol/l

—

Memory loss

412

1.12

0.28

1.3

0.14

0.34

nmol/l

—

Mandibular retrognathia

288

0.86

0.26

1.1

1.3

—

0.41

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites

0.70

0.26

1.0

1.3

—

0.61

—

Acute nephritic syndrome

1.30

0.26

1.3

1.4

—

0.41

—

Erectile dysfunction

273

1.14

0.25

1.2

1.4

0.30

0.23

nmol/l

—

Glucosamine medication

315

2426

1.04

0.24

1.2

1.3

0.21

0.27

nmol/l

0.46

178

Rheumatoid arthritis, including avohilmo

249

2394

1.04

0.24

1.2

1.3

0.18

0.22

nmol/l

0.45

163

Amblyopia ex anopsia

152

1.19

0.23

1.3

—

0.50

nmol/l

—

Motor disorders, excluding more controls

1.35

0.23

1.4

1.1

—

Congenital malformations of aortic and mitral valves

162

1.17

0.23

1.1

1.4

—

0.35

nmol/l

—

Injury of muscle and tendon at wrist and hand level

708

1.07

0.22

1.4

1.3

0.18

0.27

nmol/l

—

Schizophrenia

835

0.93

0.22

1.3

0.16

0.24

nmol/l

0.69

Other embolism and thrombosis

670

1.08

0.22

1.3

0.18

0.25

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

333

2437

1.03

0.22

1.2

1.3

0.13

0.23

nmol/l

1.92

125

Failure in dosage during surgical and medical care

0.00

0.21

0.0

1.3

—

Kyphoscoliotic heart disease

0.00

0.21

0.0

1.3

—

Traumatic amputation of hip and thigh

0.00

0.21

0.0

1.2

—

Other inherited muscular atrophy

0.00

0.21

0.0

1.5

—

Disorders of glossopharyngeal nerve

0.00

0.21

0.0

1.1

—

Telogen effluvium

0.00

0.21

0.0

1.3

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.1

—

Cyclic neutropenia

0.00

0.21

0.0

1.2

—

Acrodermatitis continua

0.00

0.21

0.0

1.2

—

Pemphigus vulgaris

0.00

0.21

0.0

1.4

—

Choroidal detachment

0.00

0.21

0.0

1.1

—

Traumatic amputation of ankle and foot

0.00

0.21

0.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.21

0.0

1.2

—

Reduction defects of upper limb

0.00

0.21

0.0

1.2

—

Bradycardia, unspecified, drug-induced

0.00

0.21

0.0

1.3

—

Other and unspecified heterotropia

0.00

0.21

0.0

1.2

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

0.21

0.0

1.3

—

Reduction defects of upper limb

0.00

0.21

0.0

1.2

—

Acanthosis nigricans

0.00

0.21

0.0

1.3

—

Injury of blood vessels of thorax

0.00

0.21

0.0

1.2

—

Complications of anaesthesia during labour and delivery

0.00

0.21

0.0

1.2

—

Haemophilus septicemia

0.00

0.21

0.0

1.2

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

0.21

0.0

1.1

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.4

—

Labyrinthine fistula

0.00

0.21

0.0

1.2

—

Fracture of femur

141

1218

1.05

0.21

1.3

0.14

0.27

nmol/l

2.82

Congenital malformations of great veins

0.00

0.21

0.0

1.4

—

Unspecified organic or symptomatic mental disorder

0.00

0.21

0.0

1.3

—

L02BB Anti-androgens

277

1.12

0.21

1.8

1.3

0.28

0.17

nmol/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.21

0.0

1.2

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.21

0.0

1.2

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.20

0.0

1.2

—

Lichenoid drug reaction

0.00

0.20

0.0

1.4

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

0.20

0.0

1.2

—

Lyme disease

190

1827

1.04

0.20

1.2

1.3

0.12

0.23

nmol/l

—

132

Vertical strabismus

136

1.18

0.20

1.1

1.3

—

0.52

nmol/l

—

Dermatitis due to ingested food

107

0.81

0.20

1.0

1.2

—

nmol/l

—

Malignant neoplasm of breast

288

1819

1.03

0.20

1.3

1.2

0.17

0.26

nmol/l

1.41

104

1.23

0.20

1.8

1.2

—

Certain zoonotic bacterial diseases

114

0.79

0.20

1.6

1.3

—

0.69

nmol/l

—

Other disorders of iris and ciliary body

1.21

0.19

1.1

1.2

—

0.61

—

Diabetic retinopathy, strict definition

119

1000

1.05

0.19

1.3

1.4

0.20

0.17

nmol/l

—

Malignant neoplasm of ovary

270

0.89

0.19

1.1

1.2

—

0.38

nmol/l

—

Prolapse and hernia of ovary and fallopian tube

163

0.85

0.19

1.2

—

0.36

—

Varicella [chickenpox]

203

1.13

0.19

1.3

—

0.27

nmol/l

—

Pemphigoid

100

1.20

0.18

1.3

—

0.70

—

Alzheimer disease, excluding more controls

504

0.94

0.17

1.4

1.3

0.11

0.15

nmol/l

—

Bullous pemphigoid

1.13

0.16

1.4

1.3

—

0.80

—

Antenatal screening

117

686

0.96

0.16

1.2

1.3

0.42

0.16

nmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

438

1.07

0.15

1.1

1.3

0.10

0.37

nmol/l

—

Carcinoma in situ of cervix uteri

438

1.07

0.15

1.2

—

0.45

nmol/l

—

Schizophrenia or delusion

188

1821

1.03

0.15

1.3

0.24

0.23

nmol/l

0.02

106

Type1 diabetes, definitions combined, early onset

263

1.10

0.15

1.7

1.3

—

0.49

nmol/l

—

Antepartum haemorrhage, not elsewhere classified

399

0.93

0.14

1.1

1.2

—

0.13

nmol/l

—

Bacterial pneumonia (organism specified)

245

2278

0.97

0.14

1.3

0.21

0.29

nmol/l

0.62

158

Left ventricular outflow tract obstruction, narrow definition

189

1.11

0.13

1.0

1.4

—

0.30

nmol/l

—

Diffuse brain injury

1.17

0.13

1.1

1.5

—

0.53

nmol/l

—

Embedded and impacted teeth

135

1077

1.03

0.13

1.5

1.3

0.13

0.32

nmol/l

—

Schizophrenia, schizotypal and delusional disorders

188

1830

1.03

0.12

1.3

0.24

0.23

nmol/l

0.06

106

Use of ropinirole

152

1.12

0.12

1.5

1.3

0.94

0.35

nmol/l

—

Oesophageal varices

158

0.89

0.12

1.1

1.3

0.18

0.39

nmol/l

—

Contact with sharp object, undetermined intent

1.16

0.11

1.3

1.4

—

0.50

—

Erythema intertrigo

105

1.14

0.11

1.3

—

0.43

nmol/l

—

Other localized connective tissue disorders

1.17

0.11

1.5

1.3

—

0.86

—

Non-small cell lung cancer, squamous, helper endpoint

136

0.88

0.11

1.0

1.3

—

0.46

nmol/l

—

Motor disorders

1.13

0.10

1.4

1.1

—

Serous carcinoma of ovary, including Hilmo

197

0.91

0.10

1.1

1.2

—

0.40

nmol/l

—

Specific developmental disorder of motor function

1.11

0.10

1.4

1.1

—

Carcinoma in situ of cervix uteri, endocervix

1.09

0.09

1.2

—

nmol/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.03

0.08

1.2

1.4

—

0.64

nmol/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.82

0.08

1.0

1.2

—

Hypothermia

0.79

0.08

1.0

1.3

—

0.54

—

Helminthiases

146

1.10

0.08

1.1

1.3

—

0.69

—

Malignant neoplasm of testis, including Hilmo

0.78

0.08

1.2

1.3

—

0.37

—

Motorcycle rider injured in noncollision transport accidents

117

1.11

0.08

1.2

1.3

—

0.50

—

Burns and corrosions of multiple and unspecified body regions

0.84

0.07

1.0

1.4

—

0.58

nmol/l

—

Other and unspecified nonorganic psychotic disorders

105

1024

1.03

0.07

1.2

1.3

0.17

0.25

nmol/l

0.69

Dislocation, sprain and strain of joints and ligaments of elbow

294

1.06

0.07

1.2

1.4

—

0.39

nmol/l

—

Varicella [chickenpox]

183

0.93

0.06

1.2

1.4

—

0.28

nmol/l

—

Syphilis

104

0.86

0.06

1.2

1.4

—

0.50

—

Syphilis

104

0.86

0.06

1.2

1.4

—

0.50

—

Benign neoplasm: Skin of ear and external auricular canal

148

1.08

0.06

1.3

1.2

—

0.59

—

Single spontaneous delivery

271

1419

1.01

0.05

1.2

1.3

0.38

0.21

nmol/l

0.58

Bacterial pneumonia, not elsewhere classified

213

1897

0.99

0.05

1.3

0.25

0.30

nmol/l

0.29

128

Procedures for purposes other than remedying health state

120

1.08

0.05

1.4

1.3

—

0.63

nmol/l

—

Diabetic retinopathy

250

1544

1.01

0.04

1.3

0.20

0.21

nmol/l

0.09

138

Dementia in other diseases classified elsewhere

179

0.95

0.03

1.3

1.2

0.33

0.52

nmol/l

—

Inflammatory disorders of breast

310

1.03

0.03

1.1

1.2

—

0.45

nmol/l

—

Major anomalies of jaw size

102

1.08

0.03

1.2

1.3

—

0.55

—

Non-small cell lung cancer, squamous

128

0.94

0.02

1.0

1.3

—

0.45

nmol/l

—

Other/unspecified rheumatoid arthritis

640

0.98

0.02

1.2

1.3

0.23

0.33

nmol/l

—

Bacterial pneumoniae

229

2029

0.99

0.01

1.3

0.23

0.29

nmol/l

0.35

136

Malignant neoplasm of ovary, including Hilmo

362

1.02

0.01

1.2

1.3

—

0.32

nmol/l

—

Bacterial meningitis

153

1.05

0.01

1.3

—

0.42

—

Other/unspecified seropositive rheumatoid arthritis

157

1578

0.99

0.01

1.2

1.3

0.22

0.24

nmol/l

—

105

Other and unspecified corneal deformities and disorders

134

1.05

0.00

1.1

1.3

—

0.52

—

Cyst of Bartholin Gland

184

1.03

0.00

1.3

1.2

—

0.36

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

156

1564

1.00

0.00

1.2

1.3

0.22

0.25

nmol/l

—

104

Viral pneumonia (known virus, not influenza)

1.04

0.00

1.5

1.2

—

0.53

—

Drug-induced cataract

1.02

0.00

1.6

1.2

—

0.54

—

Juvenile osteochondrosis

122

0.98

0.00

1.2

1.3

—

0.58

—

Drug-induced neutropenia

368

1.01

0.00

1.7

1.3

0.14

0.40

nmol/l

—

Agranulocytosis

579

1.00

0.00

1.6

1.3

0.14

0.34

nmol/l

—

Seropositive rheumatoid arthritis, wide

159

1591

1.00

0.00

1.2

1.3

0.22

0.24

nmol/l

—

107

Contact with other sharp object(s)

283

0.99

0.00

1.5

1.3

—

0.32

—

Mandibular retrognathia AND surgery (BSSO)

115

1.04

0.00

1.2

1.4

—

0.49

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.2

—

Malignant neoplasm of testis

0.86

0.00

1.2

1.4

—

0.39

—

Other conditions related to polyarteritis nodosa

0.00

0.0

1.2

—

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

0.00

0.0

1.6

—

Need for immunization against certain single viral diseases

0.00

0.0

1.2

—

Pectus carinatum

0.00

0.0

1.0

—

Osteogenesis imperfecta

0.00

0.0

1.3

—

Use of pergolide

0.00

0.0

1.3

—

Feeding problems of newborn

0.00

0.0

1.1

—

Other disorders of kidney and ureter in diseases classified elsewhere

0.00

0.0

1.4

—

Sweet's syndrome

0.00

0.0

1.5

—

Perioral dermatitis, drug-induced

0.00

0.0

1.2

—

Macular pucker, drug-induced

0.00

0.0

1.3

—

Febrile neutrophilic dermatosis [Sweet]

0.00

0.0

1.5

—

Disorders of olfactory nerve

0.00

0.0

1.2

—

Benign muscular dystrophy (Becker)

0.00

0.0

1.3

—

Carcinoma in situ of skin of lip

0.00

0.0

1.4

—

Nightmares

0.00

0.0

1.3

—

Pulmonary artery stenosis

0.00

0.0

1.4

—

Melanoma in situ of trunk

0.93

0.00

1.4

1.3

—

0.54

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

-0.00

0.0

1.2

—

Post-traumatic hydrocephalus, unspecified

0.00

-0.00

0.0

1.3

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.2

—

Other degenerative disorders of globe

0.00

-0.00

0.0

1.6

—

Sequelae of malnutrition and other nutritional deficiencies

0.00

-0.00

0.0

1.1

—

Disorders of optic chiasm

0.00

-0.00

0.0

1.2

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.4

—

Disorders of copper metabolism

0.00

-0.00

0.0

1.8

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

1.2

—

Congenital edentulism

0.00

-0.00

0.0

1.2

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.4

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

-0.00

0.0

1.6

—

Drug-induced interstitial lung disorders, unspecified

0.00

-0.00

0.0

1.3

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.1

—

Carcinoma in situ of larynx

0.00

-0.00

0.0

1.4

—

Diaper [napkin] dermatitis

0.00

-0.00

0.0

1.8

—

Congenital lactase deficiency

0.00

-0.00

0.0

1.2

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.0

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Ureter

0.00

-0.00

0.0

1.3

—

Onychogryphosis

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.3

—

Other and unspecified thalassaemias

0.00

-0.00

0.0

1.6

—

Pemphigus vegetans

0.00

-0.00

0.0

1.4

—

Cytomegaloviral pneumonitis

0.00

-0.00

0.0

1.2

—

Pemphigus erythematosus

0.00

-0.00

0.0

1.4

—

Rapidly progressive nephritic syndrome

0.00

-0.00

0.0

1.2

—

Abnormal pulmonary venous return

0.00

-0.00

0.0

1.6

—

Noonan syndrome

0.00

-0.00

0.0

1.8

—

Squamous cell neoplasms and carcinoma of rectum

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of placenta, including Hilmo

0.00

-0.00

0.0

1.3

—

0.00

-0.00

0.0

1.5

—

Marginal zone B-cell lymphoma, including Hilmo

0.96

-0.00

1.1

1.3

—

0.61

—

Aortic hypoplasia

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.6

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

Congenital absence, atresia and stenosis of small intestine

0.00

-0.00

0.0

1.7

—

Edwards' syndrome and Patau's syndrome

0.00

-0.00

0.0

1.2

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.7

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.6

—

Pectus carinatum

0.00

-0.00

0.0

1.0

—

Alcoholic myopathy

0.00

-0.00

0.0

1.2

—

Familial chondrocalcinosis

0.00

-0.00

0.0

1.3

—

Other congenital malformations of integument

0.00

-0.00

0.0

1.5

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.3

—

Ophthalmic devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

Syndactyly

0.00

-0.00

0.0

1.0

—

Pneumoconiosis due to other inorganic dusts

0.00

-0.00

0.0

1.1

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

-0.00

0.0

1.5

—

Glycosuria

0.00

-0.00

0.0

1.3

—

Polydactyly

0.00

-0.00

0.0

1.0

—

Spina bifida

0.00

-0.00

0.0

1.1

—

Traumatic secondary and recurrent haemorrhage

0.00

-0.00

0.0

1.1

—

Toxic effect of metals

0.00

-0.00

0.0

1.4

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.1

—

Burn and corrosion of respiratory tract

0.00

-0.00

0.0

1.3

—

Amputation of ankle

0.00

-0.00

0.0

1.4

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.0

—

Crushing injury of head

0.00

-0.00

0.0

1.2

—

Lichen nitidus

0.00

-0.00

0.0

1.6

—

Dislocations, sprains and strains involving multiple body regions

0.00

-0.00

0.0

1.2

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Toxic effect of pesticides

0.00

-0.00

0.0

1.2

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.3

—

Intentional self-harm by crashing of motor vehicle

0.00

-0.00

0.0

1.4

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.2

—

Exposure to smoke, fire and flames

0.90

-0.00

1.0

1.3

—

0.58

—

Assault by sharp object

0.89

-0.00

1.0

1.5

—

0.58

—

Legal intervention and operations of war

0.00

-0.00

0.0

1.3

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.2

—

Victim of lightning

0.00

-0.00

0.0

1.4

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.1

—

Forearm

0.00

-0.00

0.0

1.1

—

Filariasis

0.00

-0.00

0.0

1.3

—

Linear scleroderma

0.00

-0.00

0.0

1.7

—

Merkel cell carcinoma of skin

0.00

-0.00

0.0

1.0

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.3

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.7

—

Alpha thalassaemia

0.00

-0.00

0.0

1.0

—

Other histiocytosis syndromes

0.00

-0.00

0.0

1.2

—

Hypoplasia of dental enamel, prenatal

0.00

-0.00

0.0

1.4

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

1.4

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Erysipeloid

0.00

-0.00

0.0

1.3

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.3

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

-0.00

0.0

1.3

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

1.2

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.0

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.2

—

Fibrosis and sclerosis of liver

0.00

-0.00

0.0

1.1

—

Myiasis

0.00

-0.00

0.0

1.2

—

Lichen striatus

0.00

-0.00

0.0

1.2

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

1.2

—

Colorectal squamous cell carcinoma

0.00

-0.00

0.0

1.4

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.5

—

Tuberculosis of nervous system

0.00

-0.00

0.0

1.4

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.1

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.0

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.5

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

Myiasis

0.00

-0.00

0.0

1.2

—

Brain mixed glioma

0.00

-0.00

0.0

1.2

—

Severe mental retardation

0.00

-0.00

0.0

1.7

—

Microtia (small ears)

0.00

-0.00

0.0

1.0

—

Hereditary choroidal dystrophy

0.00

-0.00

0.0

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

3-Methoxytyramine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS